1
|
Lecce E, Nuccio S, Del Vecchio A, Conti A, Nicolò A, Sacchetti M, Felici F, Bazzucchi I. Sensorimotor integration is affected by acute whole-body vibration: a coherence study. Front Physiol 2023; 14:1266085. [PMID: 37772061 PMCID: PMC10523146 DOI: 10.3389/fphys.2023.1266085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Accepted: 09/01/2023] [Indexed: 09/30/2023] Open
Abstract
Introduction: Several whole-body vibration (WBV) effects on performance have been related to potential changes in the neural drive, motor unit firing rate, and sensorimotor integration. In the present paper, motor unit coherence analysis was performed to detect the source of neural modulation based on the frequency domain. Methods: Thirteen men [25 ± 2.1 years; Body Mass Index (BMI) = 23.9 ± 1.3 kg m2; maximal voluntary force (MVF): 324.36 ± 41.26 N] performed sustained contractions of the Tibialis Anterior (TA) at 10%MVF before and after acute WBV. The vibrating stimulus was applied barefoot through a platform to target the TA. High-Density surface Electromyography (HDsEMG) was used to record the myoelectrical activity of TA to evaluate coherence from motor unit cumulative spike-trains (CSTs). Results: Mean coherence showed a significant decrease in the alpha and low-beta bandwidths (alpha: from 0.143 ± 0.129 to 0.132 ± 0.129, p = 0.035; low-beta: from 0.117 ± 0.039 to 0.086 ± 0.03, p = 0.0001), whereas no significant changes were found in the other ones (p > 0.05). The discharge rate (DR) and the Force Covariance (CovF%) were not significantly affected by acute WBV exposure (p > 0.05). Discussion: According to the significant effects found in alpha and low-beta bandwidths, which reflect sensorimotor integration parameters, accompanied by no differences in the DR and CovF%, the present results underlined that possible neural mechanisms at the base of the previously reported performance enhancements following acute WBV are likely based on sensorimotor integration rather than direct neural drive modulation.
Collapse
Affiliation(s)
- E. Lecce
- Department of Movement, Human, and Health Sciences, Laboratory of Exercise Physiology, University of Rome “Foro Italico”, Rome, Italy
| | - S. Nuccio
- Department of Movement, Human, and Health Sciences, Laboratory of Exercise Physiology, University of Rome “Foro Italico”, Rome, Italy
| | - A. Del Vecchio
- Department Artificial Intelligence in Biomedical Engineering, Faculty of Engineering, Zentralinstitut für Medizintechnik (ZIMT), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
| | - A. Conti
- Department of Movement, Human, and Health Sciences, Laboratory of Exercise Physiology, University of Rome “Foro Italico”, Rome, Italy
| | - A. Nicolò
- Department of Movement, Human, and Health Sciences, Laboratory of Exercise Physiology, University of Rome “Foro Italico”, Rome, Italy
| | - M. Sacchetti
- Department of Movement, Human, and Health Sciences, Laboratory of Exercise Physiology, University of Rome “Foro Italico”, Rome, Italy
| | - F. Felici
- Department of Movement, Human, and Health Sciences, Laboratory of Exercise Physiology, University of Rome “Foro Italico”, Rome, Italy
| | - I. Bazzucchi
- Department of Movement, Human, and Health Sciences, Laboratory of Exercise Physiology, University of Rome “Foro Italico”, Rome, Italy
| |
Collapse
|
2
|
Pezzo G, Billi A, Carminati E, Conti A, De Gori P, Devoti R, Lucente FP, Palano M, Petracchini L, Serpelloni E, Tavani S, Chiarabba C. Seismic source identification of the 9 November 2022 M w 5.5 offshore Adriatic sea (Italy) earthquake from GNSS data and aftershock relocation. Sci Rep 2023; 13:11474. [PMID: 37455269 DOI: 10.1038/s41598-023-38150-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2023] [Accepted: 07/04/2023] [Indexed: 07/18/2023] Open
Abstract
The fast individuation and modeling of faults responsible for large earthquakes are fundamental for understanding the evolution of potentially destructive seismic sequences. This is even more challenging in case of buried thrusts located in offshore areas, like those hosting the 9 November 2022 Ml 5.7 (Mw 5.5) and ML 5.2 earthquakes that nucleated along the Apennines compressional front, offshore the northern Adriatic Sea. Available on- and offshore (from hydrocarbon platforms) geodetic observations and seismological data provide robust constraints on the rupture of a 15 km long, ca. 24° SSW-dipping fault patch, consistent with seismic reflection data. Stress increase along unruptured portion of the activated thrust front suggests the potential activation of longer portions of the thrust with higher magnitude earthquake and larger surface faulting. This unpleasant scenario needs to be further investigated, also considering their tsunamigenic potential and possible impact on onshore and offshore human communities and infrastructures.
Collapse
Affiliation(s)
- G Pezzo
- Istituto Nazionale di Geofisica e Vulcanologia, Osservatorio Nazionale Terremoti, Rome, Italy.
| | - A Billi
- Consiglio Nazionale Delle Ricerche, IGAG, Rome, Italy
| | - E Carminati
- Dip. Scienze Della Terra, Sapienza Università di Roma, Rome, Italy
| | - A Conti
- Consiglio Nazionale Delle Ricerche, IGAG, Rome, Italy
| | - P De Gori
- Istituto Nazionale di Geofisica e Vulcanologia, Osservatorio Nazionale Terremoti, Rome, Italy
| | - R Devoti
- Istituto Nazionale di Geofisica e Vulcanologia, Osservatorio Nazionale Terremoti, Rome, Italy
| | - F P Lucente
- Istituto Nazionale di Geofisica e Vulcanologia, Osservatorio Nazionale Terremoti, Rome, Italy
| | - M Palano
- Consiglio Nazionale Delle Ricerche, IGAG, Rome, Italy
- Istituto Nazionale di Geofisica e Vulcanologia, Osservatorio Etneo, Catania, Italy
| | - L Petracchini
- Consiglio Nazionale Delle Ricerche, IGAG, Rome, Italy
| | - E Serpelloni
- Istituto Nazionale di Geofisica e Vulcanologia, Sezione di Bologna, Bologna, Italy
| | - S Tavani
- Consiglio Nazionale Delle Ricerche, IGAG, Rome, Italy
- DISTAR, Università Degli Studi di Napoli "Federico II", Naples, Italy
| | - C Chiarabba
- Istituto Nazionale di Geofisica e Vulcanologia, Osservatorio Nazionale Terremoti, Rome, Italy
| |
Collapse
|
3
|
Lecce E, Nuccio S, Del Vecchio A, Conti A, Nicolò A, Sacchetti M, Felici F, Bazzucchi I. The acute effects of whole-body vibration on motor unit recruitment and discharge properties. Front Physiol 2023; 14:1124242. [PMID: 36895636 PMCID: PMC9988902 DOI: 10.3389/fphys.2023.1124242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Accepted: 02/06/2023] [Indexed: 02/23/2023] Open
Abstract
Introduction: several studies have reported improved neuromuscular parameters in response to whole-body vibration (WBV). This is likely achieved by modulation of the central nervous system (CNS). Reduced recruitment threshold (RT), which is the % of Maximal Voluntary Force (%MVF) at which a given Motor Unit (MU) is recruited, may be responsible for the force/power improvements observed in several studies. Methods: 14 men (25 ± 2.3 years; BMI = 23.3 ± 1.5 kg m2 MVF: 319.82 ± 45.74 N) performed trapezoidal isometric contractions of the tibialis anterior (TA) at 35-50-70 %MVF before and after three conditions: WBV, STAND (standing posture), and CNT (no intervention). The vibration was applied through a platform for targeting the TA. High-density surface electromyography (HDsEMG) recordings and analysis were used to detect changes in the RT and Discharge Rate (DR) of the MUs. Results: Mean motor unit recruitment threshold (MURT) reached 32.04 ± 3.28 %MVF before and 31.2 ± 3.72 %MVF after WBV, with no significant differences between conditions (p > 0.05). Additionally, no significant changes were found in the mean motor unit discharge rate (before WBV: 21.11 ± 2.94 pps; after WBV: 21.19 ± 2.17 pps). Discussion: The present study showed no significant changes in motor unit properties at the base of neuromuscular changes documented in previous studies. Further investigations are needed to understand motor unit responses to different vibration protocols and the chronic effect of vibration exposure on motor control strategies.
Collapse
Affiliation(s)
- E Lecce
- Laboratory of Exercise Physiology, Department of Movement, Human, and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - S Nuccio
- Laboratory of Exercise Physiology, Department of Movement, Human, and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - A Del Vecchio
- Department Artificial Intelligence in Biomedical Engineering, Faculty of Engineering, Zentralinstitut für Medizintechnik (ZIMT), Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
| | - A Conti
- Laboratory of Exercise Physiology, Department of Movement, Human, and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - A Nicolò
- Laboratory of Exercise Physiology, Department of Movement, Human, and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - M Sacchetti
- Laboratory of Exercise Physiology, Department of Movement, Human, and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - F Felici
- Laboratory of Exercise Physiology, Department of Movement, Human, and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - I Bazzucchi
- Laboratory of Exercise Physiology, Department of Movement, Human, and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| |
Collapse
|
4
|
Conti A, Treaba CA, Mehndiratta A, Barletta VT, Mainero C, Toschi N. An interpretable machine learning model to explain the interplay between brain lesions and cortical atrophy in multiple sclerosis. Annu Int Conf IEEE Eng Med Biol Soc 2021; 2021:3757-3760. [PMID: 34892053 DOI: 10.1109/embc46164.2021.9629526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Multiple Sclerosis (MS) is the most common cause, (after trauma) of neurological disability in young adults in Western countries. While several Magnetic Resonance Imaging (MRI) studies have demonstrated a strong association between the presence of cortical grey matter atrophy and the progression of neurological impairment in MS patients, the neurobiological substrates of cortical atrophy in MS, and in particular its relationship with white matter (WM) and cortical lesions, remain unknown. The aim of this study was to investigate the interplay between cortical atrophy and different types of lesions at Ultra-High Field (UHF) 7 T MRI, including cortical lesions and lesions with a susceptibility rim (a feature which histopathological studies have associated with impaired remyelination and progressive tissue destruction). We combined lesion characterization with a recent machine learning (ML) framework which includes explainability, and we were able to predict cortical atrophy in MS from a handful of lesion-related features extracted from 7 T MR imaging. This highlights not only the importance of UHF MRI for accurately evaluating intracortical and rim lesion load, but also the differential contributions that these types of lesions may bring to determine disease evolution and severity. Also, we found that a small subset of features [WM lesion volume (not considering rim lesions), patient age and WM lesion count (not considering rim lesions), intracortical lesion volume] carried most of the prediction power. Interestingly, an almost opposite pattern emerged when contrasting cortical with WM lesion load: WM lesion load is most important when it is small, whereas cortical lesion load behaves in the opposite way.Clinical Relevance- Our results suggest that disconnection and axonal degeneration due to WM lesions and local cortical demyelination are the main factors determining cortical thinning. These findings further elucidate the complexity of MS pathology across the whole brain and the need for both statistical and mechanistic approaches to understanding the etiopathogenesis of lesions.
Collapse
|
5
|
Delbon P, Maghin F, Conti A. Medically assisted suicide in Italy: the recent judgment of the Constitutional Court. Clin Ter 2021; 172:193-196. [PMID: 33956035 DOI: 10.7417/ct.2021.2312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Abstract Medically assisted suicide is considered among the most contro-versial of the current bioethical debate in our Country. In the Italian legal system, we are lacking specific discipline of this practice, as it is covered by the general legal forms applicable to crimes against life. The Constitutional Court, with Decision No. 242/2019, declared the illegitimacy of Art. 580 of the Criminal Code (instigation to suicide), in the part not excluding the punishment of those who facilitates the execution of the intention to commit suicide, independently and freely formed, by a person kept alive by life support and suffering an irreversible disease, source of physical or psychological suffering that the person deems intolerable, but who is fully capable of making free and conscious decisions. The Constitutional Court found that the current regulatory fra-mework concerning the end of life leaves certain situations constitutio-nally worthy of protection and to be balanced with other constitutionally relevant assets without adequate protection. The Court has identified the conditions that can justify third-party assistance in ending the life of a sick person. The judges envisaged the possibility of including this discipline under Law No. 219/2017, but this hypothesis is not shared by the Italian National Bioethics Committee.
Collapse
Affiliation(s)
- P Delbon
- Forensic Medicine Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.,Centre of Bioethics Research, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia Italy
| | - F Maghin
- Forensic Medicine Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy
| | - A Conti
- Forensic Medicine Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.,Centre of Bioethics Research, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia Italy
| |
Collapse
|
6
|
Guzzo S, Nazzani S, Vaccaro C, Di Benedetto R, Signorini C, Vizziello D, Conti A, Finkelberg E, Bortolussi G, Acquati P, De Vincetiis C, Carmignani L. Radical nephrectomy and caval thrombectomy with heart beating technique for renal cell cancer with tumor thrombus extension into inferior vena cava and right atrium: A less invasive multidisciplinary approach. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01005-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
7
|
Conti A, Burastero GJ, Hales BJ, Breda D, Alessio M, Burastero SE. IgE reactivity to house dust mite allergen components in sensitized asymptomatic subjects: a role for Der p 20. J BIOL REG HOMEOS AG 2021; 35:669-676. [PMID: 33851528 DOI: 10.23812/21-07-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- A Conti
- Proteome Biochemistry, IRCCS - San Raffaele Scientific Institute, Milan, Italy
| | - G J Burastero
- Proteome Biochemistry, IRCCS - San Raffaele Scientific Institute, Milan, Italy
| | - B J Hales
- Telethon Kids Institute, Center for Child Health Research, University of Western Australia, Perth, Australia
| | - D Breda
- Proteome Biochemistry, IRCCS - San Raffaele Scientific Institute, Milan, Italy
| | - M Alessio
- Proteome Biochemistry, IRCCS - San Raffaele Scientific Institute, Milan, Italy
| | - S E Burastero
- Cellular and Molecular Allergology Unit, IRCCS - San Raffaele Hospital, Milan Italy
| |
Collapse
|
8
|
Genovese C, Squeri R, Alessi V, Conti A, D'Amato S, Mazzitelli F, Costa G, Squeri A. Adherence to the three Italian screening in a sample of women (and men) in the Southern Italy. Clin Ter 2021; 171:e75-e79. [PMID: 33346333 DOI: 10.7417/ct.2021.2287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
INTRODUCTION Although scientific evidence shows the numerous benefits of screening programs, in Italy. There is a great disparity between the regional coverage of the North and South despite the screening programs have been activated for several years in all regions even with territorial differences. OBJECTIVE The aim of our study was to evaluate the knowledge and adherence to different screenings in the population, the influence exercised by the local health authority the role of the general practitioner in advising and referring patients to screening tests and the main causes of refuse. MATERIAL AND METHODS The study was carried out, from December 2019 to May 2020, through the administration of anonymous self-filled "ad hoc" questionnaires to women and men over 26 years old. RESULTS in our sample 36% have never performed a breast check and 39% of the interviewees never had a mammogram; for cervical cancer 25% did not ever perform screening and 65% did not have an indication by GP. The worst result was found for colorectal cancer (only 27% of the sample performed the screening). The role of GP was fundamental for and similar to other studies, was fundamental in fact,similar to other studies the most frequent reported reasons for the non-execution of screening were the lack of physicians' advice, follwed by lack of time, the most frequent reported reasons for the non-execution of screening were the lack of physicians' advice, a lack of time, fear of cancer and embarrassment at visiting a gynaecologist. DISCUSSION AND CONCLUSIONS the study carried out found that despite the knowledge of the oncological disease and the possibilities of prevention is fairly rooted in the population, adherence to the screening is quite inadequate, especially as regards colorectal cancer.
Collapse
Affiliation(s)
- C Genovese
- PhD students in Translational Molecular Medicine and Surgery, XXXV cycle, University of Messina - Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina
| | - R Squeri
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina
| | - V Alessi
- Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Messina
| | - A Conti
- Health Management, Lentini Hospital, Sicily
| | - S D'Amato
- Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Messina
| | - F Mazzitelli
- Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Messina
| | - G Costa
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina
| | - A Squeri
- Department of Human Pathology of the adult and developmental age "Gaetano Barresi", University of Messina, Italy
| |
Collapse
|
9
|
Carducci AL, Agodi A, Ancona C, Angelini P, Bagordo F, Barbone F, Birbaum L, Carreri V, Casuccio A, Conti A, Conversano M, De Donno A, De Giglio O, Desiante F, Di Pietro A, Dogliotti E, Donato F, Fara GM, Fiore M, Forastiere F, Giammanco G, Izzotti A, Montagna MT, Oliveri Conti G, Petronio MG, Sciacca S, Signorelli C, Testai E, Verani M, Vinceti M, Vitale F, Ferrante M, Adani G, Berghella L, Calia C, Calzolari R, Canale A, Castiglione D, Conti A, Copat C, Cristaldi A, Cuffari G, Coronel Vargas G, De Vita E, De Nard F, Federigi I, Filippini T, Grasso A, Leonardi N, Letzgus M, Lo Bianco G, Mazzucco W, Nicolosi I, Orlandi P, Paladino G, Pizzo S, Pousis C, Raffo M, Rivolta S, Scarpitta F, Trani G, Triggiano F, Tumbarello A, Vecchio V, Zuccarello P, Vassallo M. Impact of the environment on the health: From theory to practice. Environ Res 2021; 194:110517. [PMID: 33271142 DOI: 10.1016/j.envres.2020.110517] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Revised: 11/18/2020] [Accepted: 11/19/2020] [Indexed: 06/12/2023]
Abstract
The Erice 56 Charter titled "Impact of the environment on the health: from theory to practice" was unanimously approved at the end of the 56th course of the "International School of Epidemiology and Preventive Medicine G. D'Alessandro" held from 3rd to November 7, 2019 in Erice - Sicily (Italy) and promoted by the Study Group of "Environment and Health" of the Italian Society of Hygiene, Preventive Medicine and Public Health. The course, that included lectures, open discussions and guided working groups, was aimed to provide a general training on epidemiological and toxicological aspects of the environmental health impact, to be used by public health professionals for risk assessment, without forgetting the risk communications. At the end of the course 12 key points were agreed among teachers and students: they underlined the need of specific training and research, in the perspective of "One Health" and "Global Health", also facing emerging scientific and methodological issues and focusing on communication towards stakeholders. This Discussion highlight the need to improve knowledge of Health and Environment topic in all sectors of health and environmental prevention and management.
Collapse
Affiliation(s)
- A L Carducci
- Department of Biology, University of Pisa, Italy
| | - A Agodi
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - C Ancona
- Department of Epidemiology of the Regional Health Service, Lazio Region, Rome, Italy
| | - P Angelini
- Public Health Service, Emilia-Romagna Region, Italy
| | - F Bagordo
- Department of Biological and Environmental Sciences and Technologies, University of Salento, Italy
| | - F Barbone
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy
| | - L Birbaum
- Office of the Director, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, USA
| | - V Carreri
- Past-President of Italian Society of Hygiene (SItI), Italy
| | - A Casuccio
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, "G. D'Alessandro", University of Palermo, Italy
| | - A Conti
- Regional Agency for Environmental Protection of Sicily, Italy
| | - M Conversano
- Department of Public Health, ASL, Taranto, Italy
| | - A De Donno
- Department of Biological and Environmental Sciences and Technologies, University of Salento, Italy
| | - O De Giglio
- Department of Biomedical Sciences and Human Oncology, Section of Hygiene, University of Bari Aldo Moro, Italy
| | - F Desiante
- Department of Prevention, Local Health Authority of Taranto, Taranto, Italy
| | - A Di Pietro
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy
| | - E Dogliotti
- Department of Environmental and Health. Istituto Superiore di Sanità. Rome, Italy
| | - F Donato
- Department of Medical and Surgical Specialties, Radiological Sciences, And Public Health, University of Brescia, Italy
| | - G M Fara
- International School of Epidemiology and Preventive Medicine «Giuseppe D'Alessandro», Erice, Trapani, Italy
| | - M Fiore
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - F Forastiere
- Department of Epidemiology of the Regional Health Service, Lazio Region, Rome, Italy
| | - G Giammanco
- International School of Epidemiology and Preventive Medicine «Giuseppe D'Alessandro», Erice, Trapani, Italy
| | - A Izzotti
- Department of Health Sciences, University of Genoa, Genoa, Italy
| | - M T Montagna
- Department of Biomedical Sciences and Human Oncology, Section of Hygiene, University of Bari Aldo Moro, Italy
| | - G Oliveri Conti
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - M G Petronio
- Health and Environment-Department of Prevention, Local Health Authority-Empoli, Florence, Italy
| | - S Sciacca
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - C Signorelli
- University Vita-Salute San Raffaele, Milan, Italy
| | - E Testai
- Istituto Superiore di Sanità, Environment & Health Dept., Rome, Italy
| | - M Verani
- Department of Biology, University of Pisa, Italy
| | - M Vinceti
- Section of Public Health, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - F Vitale
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, "G. D'Alessandro", University of Palermo, Italy
| | - M Ferrante
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy.
| | - G Adani
- Section of Public Health, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - L Berghella
- Section of Public Health, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - C Calia
- Department of Biomedical Sciences and Human Oncology, Section of Hygiene, University of Bari Aldo Moro, Italy
| | - R Calzolari
- Regional Agency for Environmental Protection of Sicily, Italy
| | - A Canale
- Department of Biology, University of Pisa, Italy
| | - D Castiglione
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - A Conti
- Regional Agency for Environmental Protection of Sicily, Italy
| | - C Copat
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - A Cristaldi
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - G Cuffari
- Regional Agency for Environmental Protection of Sicily, Italy
| | - G Coronel Vargas
- Department of Health Sciences, University of Genoa, Genoa, Italy
| | - E De Vita
- Department of Biology, University of Pisa, Italy
| | | | - I Federigi
- Department of Biology, University of Pisa, Italy
| | - T Filippini
- Section of Public Health, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - A Grasso
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - N Leonardi
- University Center for the Protection and Management of Natural Environments and Agrosystems (CUTGANA), University of Catania, Italy
| | | | | | - W Mazzucco
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, "G. D'Alessandro", University of Palermo, Italy
| | - I Nicolosi
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - P Orlandi
- Local Health Authority of Rome, Italy
| | - G Paladino
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - S Pizzo
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, "G. D'Alessandro", University of Palermo, Italy
| | - C Pousis
- Department of Biomedical Sciences and Human Oncology, Section of Hygiene, University of Bari Aldo Moro, Italy
| | - M Raffo
- Local Health Authority of Rome, Italy
| | | | - F Scarpitta
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, "G. D'Alessandro", University of Palermo, Italy
| | - G Trani
- Central Health Department of the Friuli Venezia Giulia Region, Trieste, Italy
| | - F Triggiano
- Department of Biomedical Sciences and Human Oncology, Section of Hygiene, University of Bari Aldo Moro, Italy
| | | | - V Vecchio
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - P Zuccarello
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| | - M Vassallo
- Department of Medical Science, Surgical and Advanced Technologies "G.F. Ingrassia", University of Catania, Italy
| |
Collapse
|
10
|
Conti A, Bogazzi I, Mazzucchelli M, Covelli A, Molesti D, Catarzi S, Renzi N, Panpana A, Tomisti L, Leorin M, Ghiadoni L. Incidence of major bleeding events and outcome of patients of 80 and 90 years or older with ongoing anticoagulants: five-year survey in northwest Tuscany. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objective
To search for rates of major bleeding events in patients (pts) with age ≥80 or ≥90 years (y.) with ongoing anticoagulants referred to hospital.
Methods
Patients complaining any bleeding events were submitted to propensity score matching for major bleeding and stratified according to age ≥80 or ≥90 y. and warfarin or direct oral anticoagulants (DOACs).
Setting
A General Hospital, northwest Tuscany, five-year survey, 385,650 visits; catchment area 197,722 inhabitants, of whom 18,373 on warfarin and 14,808 on DOACs. Out of DOACs, dabigatran and rivaroxaban were available in the catchment area since 5 y., apixaban 4 y. and edoxaban 3 y; 5,553 pts received rivaroxaban, 4,602 dabigatran, 3,147 apixaban and 1,506 edoxaban.
Endpoint
Primary endpoint was one-week death, and incidence of major bleeding.
Results
Out of 7,474 pts considered, 2504 (33.5%) pts were older than 80 y., of whom 518 (6.8%) were older than 90 y; they were enrolled in the study. Overall, 253 (10.1%) showed history of stroke/TIA, 578 (22.9%) atrial fibrillation, 277 (11.1%) cancer, 177 (7.0%) congestive heart failure, 33 (1.3%) pulmonary thromboembolism.
Of these 7,474 pts 1,040 (41.5%) showed major bleeding: 621 (24.8%) were gastrointestinal of which 258 (10.3%) of the upper tract and 363 (14.5%) of the lower tract; 794 (31.7%) were brain haemorrhage; the remaining patients showed other bleeding.
Overall, 435 (5.8%) pts needed reversal anticoagulation, 325 (4.4%) red blood cell pack, and 2879 (38.5%) admission. Eventually, 127 pts have been readmitted to the hospital for ischemic stroke and 499 for new bleeding event. CHA2D2VASc-score was 2.5±1.5 and Charlston Comorbidity Index was 3.4±2.3.
Out of 2,504 patients older than 80 y., 367 (14,7%) received anticoagulants (including heparin) of which 134 (5.4%) received warfarin versus 63 (2.5%) DOACs (p<0.001); 24 dabigatran, 19 rivaroxaban, 17 apixaban, and 3 edoxaban. Overall 88 (3.5%) needed reversal anticoagulation, 128 pts (5.1%) red blood cell pack, and 825 (32.9%) pts admission.
One-week mortality rate as follows: anticoagulants 35 (1.4%) versus DOACs 6 (0.2%), p<0.001; dabigatran 0, rivaroxaban 2, apixaban 2, edoxaban 2.
Out of 518 patients older than 90 y., 98 (18.9%) received anticoagulants (including heparin) of whom 44 (8.5%) received warfarin; 11 (2.1%) DOACs (p<0.001); 4 dabigatran, 2 rivaroxaban, 4 apixaban, and 1 edoxaban. Overall 24 (4.6%) needed reversal anticoagulation, 50 (9.7%) red blood cell pack, and 203 (39.2%) admission.
One-week mortality rate as follows: anticoagulants 10 (1.9%) versus DOACs 1 (0.2%), p<0.001; dabigatran 0, rivaroxaban 0, apixaban 1 (0.2%), edoxaban 0.
Conclusion
Patients of 80 y. and even 90 y. or older, with ongoing warfarin, showed higher percentage of major bleeding events and mortality rate versus DOACs. Within DOACs, edoxaban was more likely to show lower rate of major bleeding events, without differences in death rate.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- A Conti
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - I.C Bogazzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - M Mazzucchelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A Covelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - D Molesti
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - S Catarzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - N Renzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A Panpana
- North-West District Tuscany HealthCare, Apuane General Hospital, Internal and Geriatric Medicine, Massa-Carrara, Italy
| | - L Tomisti
- North-West District Tuscany HealthCare, Apuane General Hospital, Internal and Geriatric Medicine, Massa-Carrara, Italy
| | - M Leorin
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| | - L Ghiadoni
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| |
Collapse
|
11
|
Signorini C, Mazzaccaro D, Malacrida G, Vaccaro C, Guzzo S, Blezien O, Molinari F, Vizziello D, Conti A, Nano G, Carmignani L. Antegrade versus retrograde common iliac artery revascularization and occurrence of erectile disfunction. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35338-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
12
|
Talamonti M, Galluzzo M, Chiricozzi A, Quaglino P, Fabbrocini G, Gisondi P, Marzano AV, Potenza C, Conti A, Parodi A, Belloni Fortina A, Bardazzi F, Argenziano G, Rongioletti F, Stingeni L, Micali G, Loconsole F, Venturini M, Bongiorno MR, Feliciani C, Rubegni P, Amerio P, Fargnoli MC, Pigatto P, Savoia P, Nisticò SP, Giustini S, Carugno A, Cannavò SP, Rech G, Prignano F, Offidani A, Lombardo M, Zalaudek I, Bianchi L, Peris K. Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol 2020; 34:e770-e772. [PMID: 32735716 PMCID: PMC7436412 DOI: 10.1111/jdv.16841] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Revised: 07/15/2020] [Accepted: 07/21/2020] [Indexed: 01/07/2023]
Affiliation(s)
- M Talamonti
- Dermatology Department, University of Rome 'Tor Vergata', Rome, Italy
| | - M Galluzzo
- Dermatology Department, University of Rome 'Tor Vergata', Rome, Italy
| | - A Chiricozzi
- Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.,Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy
| | - P Quaglino
- Medical Sciences Department, Dermatologic Clinic, University of Turin, Turin, Italy
| | - G Fabbrocini
- Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
| | - P Gisondi
- Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy
| | - A V Marzano
- Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.,Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
| | - C Potenza
- Department of Medico-Surgical Sciences and Biotechnologies, Dermatology Unit 'Daniele Innocenzi' Sapienza University of Rome - Polo Pontino, Rome, Italy
| | - A Conti
- Dermatologic Unit, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy
| | - A Parodi
- Ospedale-Policlinico San Martino IRCCS Genova, Clinica Dermatologica DiSSal Università di Genova, Genova, Italy
| | - A Belloni Fortina
- Dermatology Unit - Department of Medicine DIMED, University of Padova, Padova, Italy
| | - F Bardazzi
- Dermatology Division, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy
| | - G Argenziano
- Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy
| | - F Rongioletti
- Section of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
| | - L Stingeni
- Dermatology Section, Department of Medicine, University of Perugia, Perugia, Italy
| | - G Micali
- Dermatology Clinic, University of Catania, Catania, Italy
| | - F Loconsole
- Department of Biomedical Science and Human Oncology, Unit of Dermatology, University of Bari, Bari, Italy
| | - M Venturini
- Department of Dermatology, ASST Spedali Civili of Brescia, University of Brescia, Brescia, Italy
| | - M R Bongiorno
- Section of Dermatology, Department of Health Promotion, Maternal-Infant, Internal Medicine and Specialization, University of Palermo, Palermo, Italy
| | - C Feliciani
- Department of Medicine and Surgery, Section of Dermatology, University of Parma, Parma, Italy
| | - P Rubegni
- Dermatology Unit, Department of Medical, Surgical and Neurosciences, University of Siena, Italy
| | - P Amerio
- Department of Medicine and Aging Science, Dermatologic Clinic, G. D'Annunzio University, Chieti, Italy
| | - M C Fargnoli
- Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy
| | - P Pigatto
- Department of Biomedical, Surgical and Dental Sciences, Clinical Dermatology, IRCCS Galeazzi Orthopaedic Institute, University of Milan, Milan, Italy
| | - P Savoia
- Department of Health Science, Dermatologic Clinic, University of Eastern Piedmont, Novara, Italy
| | - S P Nisticò
- Dermatology Unit, Department of Health Sciences, Università Magna Graecia, Catanzaro, Italy
| | - S Giustini
- Department of Dermatology, Sapienza' University of Rome, Rome, Italy
| | - A Carugno
- Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy
| | - S P Cannavò
- Dermatology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - G Rech
- Division of Dermatology, Santa Chiara Hospital, Trento, Italy
| | - F Prignano
- Dermatology Clinic, Department of Health Sciences, University of Florence, Florence, Italy
| | - A Offidani
- Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic University of the Marche Region, Ancona, Italy
| | - M Lombardo
- Unit of Dermatological Diseases, ASST Sette Laghi, Ospedale di Circolo, Varese, Italy
| | - I Zalaudek
- Department of Dermatology, University of Trieste, Trieste, Italy
| | - L Bianchi
- Dermatology Department, University of Rome 'Tor Vergata', Rome, Italy
| | - K Peris
- Dermatologia, Dipartimento Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.,Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy
| | | |
Collapse
|
13
|
Gisondi P, Piaserico S, Conti A, Naldi L. Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice. J Eur Acad Dermatol Venereol 2020; 34:1196-1201. [PMID: 32320091 PMCID: PMC7264567 DOI: 10.1111/jdv.16515] [Citation(s) in RCA: 72] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2020] [Accepted: 04/08/2020] [Indexed: 12/18/2022]
Abstract
Since the first case of 'pneumonia of unknown aetiology' was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognized thereafter as 'severe acute respiratory syndrome coronavirus 2' (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of coronavirus disease-19 (COVID-19) and satisfying the epidemiological criteria for a label of 'pandemic'. The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patient assistance and new research needs to be addressed. It is not known yet if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes.
Collapse
Affiliation(s)
- P Gisondi
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| | - S Piaserico
- Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - A Conti
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| | - L Naldi
- Study Centre of the Italian Group for the Epidemiologic Research in Dermatology (GISED), Bergamo, Italy.,Department of Dermatology, San Bortolo Hospital, Vicenza, Italy
| |
Collapse
|
14
|
Bianchi R, Mistretta F, Collà Ruvolo C, Conti A, Luzzago S, Vizziello D, Catellani M, Di Trapani E, Cozzi G, Ferro M, Cordima G, Brescia A, Bottero D, Verweij F, Matei D, Musi G, De Cobelli O. Robot-assisted intracorporeal orthotopic ileal neobladder: Description of the “Shell” technique. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34208-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
15
|
Luzzago S, Sabatini I, Garelli G, Mistretta F, Conti A, Catellani M, Di Trapani E, Bianchi R, Cozzi G, Alessi S, Pricolo P, Ferro M, Metei D, Musi G, Petralia G, De Cobelli O. MRI-targeted or standard biopsy for prostate cancer diagnosis in biopsy naïve patients. The PRECISION trial follow-up. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)33754-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
16
|
Dattola A, Balato A, Megna M, Gisondi P, Girolomoni G, De Simone C, Caldarola G, Cama E, Piaserico S, Fargnoli M, Fidanza R, Parodi A, Burlando M, Offidani A, Diotallevi F, Potenza C, Conti A, Chiricozzi A, Campione E, Bianchi L. Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real‐world multicentre Italian study. J Eur Acad Dermatol Venereol 2020; 34:2839-2845. [DOI: 10.1111/jdv.16606] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 04/21/2020] [Indexed: 01/11/2023]
Affiliation(s)
- A. Dattola
- Department of Dermatology University of Rome“Tor Vergata” Rome Italy
| | - A. Balato
- Department of Advanced Biomedical Sciences University of Naples Federico II Naples Italy
| | - M. Megna
- Department of Clinical Medicine and Surgery University of Naples Federico II Naples Italy
| | - P. Gisondi
- Section of Dermatology and Venereology Department of Medicine University of Verona Verona Italy
| | - G. Girolomoni
- Section of Dermatology and Venereology Department of Medicine University of Verona Verona Italy
| | - C. De Simone
- Institute of Dermatology Catholic University Rome Italy
- Dermatology Unit Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy
| | - G. Caldarola
- Institute of Dermatology Catholic University Rome Italy
| | - E. Cama
- Dermatology Unit Department of Medicine University of Padua Padua Italy
| | - S. Piaserico
- Dermatology Unit Department of Medicine University of Padua Padua Italy
| | - M.C. Fargnoli
- Department Dermatology Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy
| | - R. Fidanza
- Department Dermatology San Salvatore HospitalUniversity of L'Aquila L'Aquila Italy
| | - A. Parodi
- Section of Dermatology DISSAL San Martino‐IST Polyclinic HospitalUniversity of Genoa Genoa Italy
| | - M. Burlando
- Section of Dermatology DISSAL San Martino‐IST Polyclinic HospitalUniversity of Genoa Genoa Italy
| | - A. Offidani
- Dermatology Unit Department of Clinical and Molecular Sciences Polytechnic Marche University Ancona Italy
| | - F. Diotallevi
- Dermatology Unit Department of Clinical and Molecular Sciences Polytechnic Marche University Ancona Italy
| | - C. Potenza
- Department of Medical‐Surgical Sciences and Bio‐Technologies Sapienza University of Rome, Polo Pontino Terracina Italy
| | - A. Conti
- Dermatology Unit Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine University of Modena and Reggio Emilia Modena Italy
| | - A. Chiricozzi
- Institute of Dermatology Catholic University Rome Italy
- Dermatology Unit Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy
- Dermatology Unit Department of Clinical and Experimental Medicine University of Pisa Pisa Italy
| | - E. Campione
- Department of Dermatology University of Rome“Tor Vergata” Rome Italy
| | - L. Bianchi
- Department of Dermatology University of Rome“Tor Vergata” Rome Italy
| |
Collapse
|
17
|
Fahmy DH, El-Amawy HS, El-Samongy MA, Fouda AA, Soliman SH, El-Kady A, Farnetani F, Conti A, Zoeir A, Eissa A, Eissa R, Puliatti S, Sighinolfi MC, Rocco B, Pellacani G. COVID-19 and dermatology: a comprehensive guide for dermatologists. J Eur Acad Dermatol Venereol 2020; 34:1388-1394. [PMID: 32428303 PMCID: PMC7276795 DOI: 10.1111/jdv.16545] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Linked articles: COVID‐19 SPECIAL FORUM. J Eur Acad Dermatol Venereol 2020; 34: e291–e310.
Collapse
Affiliation(s)
- D H Fahmy
- Dermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - H S El-Amawy
- Dermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - M A El-Samongy
- Dermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - A A Fouda
- Dermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - S H Soliman
- Dermatology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - A El-Kady
- Dermatology Department, El-Menshawy Hospital, Ministry of Health & Population, Tanta, Egypt
| | - F Farnetani
- Dermatology Department, University of Modena & Reggio Emilia, Modena, Italy
| | - A Conti
- Dermatology Department, Azienda Ospedaliero Universitaria of Modena, Modena, Italy
| | - A Zoeir
- Urology Department, University of Modena & Reggio Emilia, Modena, Italy.,Urology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - A Eissa
- Urology Department, University of Modena & Reggio Emilia, Modena, Italy.,Urology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - R Eissa
- Microbiology & Virology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
| | - S Puliatti
- Urology Department, University of Modena & Reggio Emilia, Modena, Italy.,ORSI Academy, Melle, Belgium
| | - M C Sighinolfi
- Urology Department, University of Modena & Reggio Emilia, Modena, Italy
| | - B Rocco
- Urology Department, University of Modena & Reggio Emilia, Modena, Italy
| | - G Pellacani
- Dermatology Department, University of Modena & Reggio Emilia, Modena, Italy
| |
Collapse
|
18
|
Conti A, Lasagni C, Bigi L, Pellacani G. Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs. J Eur Acad Dermatol Venereol 2020; 34:e360-e361. [PMID: 32379913 PMCID: PMC7267267 DOI: 10.1111/jdv.16587] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- A Conti
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| | - C Lasagni
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| | - L Bigi
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| | - G Pellacani
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
19
|
Gisondi P, Facheris P, Dapavo P, Piaserico S, Conti A, Naldi L, Cazzaniga S, Malagoli P, Costanzo A. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. Br J Dermatol 2020; 183:373-374. [PMID: 32343839 PMCID: PMC7267283 DOI: 10.1111/bjd.19158] [Citation(s) in RCA: 88] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- P Gisondi
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Italy
| | - P Facheris
- Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.,Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
| | - P Dapavo
- Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy
| | - S Piaserico
- Section of Dermatology, Department of Medicine, University of Padua, Padova, Italy
| | - A Conti
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| | - L Naldi
- Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.,Centro Studi GISED, Bergamo, Italy
| | - S Cazzaniga
- Centro Studi GISED, Bergamo, Italy.,Department of Dermatology, Inselspital University Hospital of Bern, Bern, Switzerland
| | - P Malagoli
- Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy
| | - A Costanzo
- Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
| |
Collapse
|
20
|
Gisondi P, Bellinato F, Conti A, Dapavo P, Piaserico S, De Simone C, Chiricozzi A, Dattola A, Malagoli P, Malara G, Campanati A, Burlando M, Esposito M, Gallo L, Girolomoni G. Consensus on the place in therapy of TNF‐α inhibitors in the treatment of patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2020; 34:e470-e472. [DOI: 10.1111/jdv.16380] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Accepted: 03/10/2020] [Indexed: 01/13/2023]
Affiliation(s)
- P. Gisondi
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| | - F. Bellinato
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| | - A. Conti
- Department of Surgical Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine Dermatology Unit University of Modena and Reggio Emilia Modena Italy
| | - P. Dapavo
- Department of Biomedical Science and Human Oncology Second Dermatologic ClinicUniversity of Turin Turin Italy
| | - S. Piaserico
- Section of Dermatology Department of Medicine University of Padua Padova Italy
| | - C. De Simone
- Institute of Dermatology Catholic University Rome Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy
| | - A. Chiricozzi
- Institute of Dermatology Catholic University Rome Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy
| | - A. Dattola
- Department of Dermatology University of Rome Tor Vergata Rome Italy
| | - P. Malagoli
- Dermatology Unit Azienda Ospedaliera San Donato Milanese Milan Italy
| | - G. Malara
- Dermatology Unit Grande Ospedale Metropolitano Bianchi Melacrino Morelli Reggio Calabria Italy
| | - A. Campanati
- Department of Clinical and Molecular Sciences Dermatological Clinic Polytechnic Marche University Ancona Italy
| | - M. Burlando
- Section of Dermatology Department of Health Sciences San Martino University Hospital IRCCS University of Genoa Genoa Italy
| | - M. Esposito
- Dermatology Unit Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy
| | - L. Gallo
- Section of Dermatology Department of Clinical Medicine and Surgery University of Naples Federico II Naples Italy
| | - G. Girolomoni
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| |
Collapse
|
21
|
Gisondi P, Virga C, Piaserico S, Meneguzzo A, Odorici G, Conti A, Girolomoni G. Switching from one infliximab biosimilar (CT‐P13) to another infliximab biosimilar (SB2) in patients with chronic plaque psoriasis. Br J Dermatol 2020; 183:397-398. [DOI: 10.1111/bjd.19013] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- P. Gisondi
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| | - C. Virga
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| | - S. Piaserico
- Department of Medicine Section of Dermatology and Venereology University of Padua Padua Italy
| | - A. Meneguzzo
- Department of Medicine Section of Dermatology and Venereology University of Padua Padua Italy
| | - G. Odorici
- Department of Head and Neck Surgery Section of Dermatology Azienda Ospedaliero Universitaria Policlinico di Modena Modena Italy
| | - A. Conti
- Department of Head and Neck Surgery Section of Dermatology Azienda Ospedaliero Universitaria Policlinico di Modena Modena Italy
| | - G. Girolomoni
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| |
Collapse
|
22
|
Mantovani A, Lunardi G, Bonapace S, Dugo C, Altomari A, Molon G, Conti A, Bovo C, Laaksonen R, Byrne CD, Bonnet F, Targher G. Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease. Diabetes Metab 2020; 47:101152. [PMID: 32283179 DOI: 10.1016/j.diabet.2020.03.003] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Revised: 03/21/2020] [Accepted: 03/31/2020] [Indexed: 10/24/2022]
Abstract
AIM Plasma levels of certain ceramides are increased in patients with ischemic heart disease (IHD). Many risk factors for IHD are also risk factors for chronic kidney disease (CKD), but it is currently uncertain whether plasma ceramide levels are increased in patients with CKD. METHODS We measured six previously identified high-risk plasma ceramide concentrations [Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/20:0), Cer(d18:1/22:0), Cer(d18:1/24:0) and Cer(d18:1/24:1)] in 415 middle-aged individuals who attended our clinical Cardiology and Diabetes services over a period of 9 months. RESULTS A total of 97 patients had CKD (defined as e-GFRCKD-EPI<60ml/min/1.73m2 and/or urinary albumin-to-creatinine ratio≥30mg/g), 117 had established IHD and 242 had type 2 diabetes. Patients with CKD had significantly (P=0.005 or less) higher levels of plasma Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/20:0), Cer(d18:1/22:0), Cer(d18:1/24:0), and Cer(d18:1/24:1) compared to those without CKD. The presence of CKD remained significantly associated with higher levels of plasma ceramides (standardized beta coefficients ranging from 0.124 to 0.227, P<0.001) even after adjustment for body mass index, smoking, hypertension, diabetes, prior IHD, plasma LDL-cholesterol, hs-C-reactive protein levels and use of any lipid-lowering medications. Notably, more advanced stages of CKD and abnormal albuminuria were both associated (independently of each other) with increased levels of plasma ceramides. These results were consistent in all subgroups considered, including patients with and without established IHD or those with and without diabetes. CONCLUSION Increased levels of plasma ceramides are associated with CKD independently of pre-existing IHD, diabetes and other established cardiovascular risk factors.
Collapse
Affiliation(s)
- A Mantovani
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126 Verona, Italy
| | - G Lunardi
- Medical Analysis Laboratory, "IRCCS Sacro Cuore - Don Calabria" Hospital, Negrar, VR, Italy
| | - S Bonapace
- Division of Cardiology, "IRCCS Sacro Cuore - Don Calabria" Hospital, Negrar, VR, Italy
| | - C Dugo
- Division of Cardiology, "IRCCS Sacro Cuore - Don Calabria" Hospital, Negrar, VR, Italy
| | - A Altomari
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126 Verona, Italy
| | - G Molon
- Division of Cardiology, "IRCCS Sacro Cuore - Don Calabria" Hospital, Negrar, VR, Italy
| | - A Conti
- Medical Analysis Laboratory, "IRCCS Sacro Cuore - Don Calabria" Hospital, Negrar, VR, Italy
| | - C Bovo
- Medical Direction, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy
| | - R Laaksonen
- Zora Biosciences Oy, Espoo, Finland; Finnish Cardiovascular Research Center Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere University Hospital, Tampere, Finland
| | - C D Byrne
- Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK; Nutrition and Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK
| | - F Bonnet
- University Hospital of Rennes, University of Rennes 1, CHU, Rennes, France
| | - G Targher
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Stefani, 1, 37126 Verona, Italy.
| |
Collapse
|
23
|
Filippi F, Odorici G, Conti A, Di Lernia V, Di Nuzzo S, Chessa MA, Corazza M, Patrizi A, Bardazzi F. Biological therapy in psoriatic patients whishing fatherhood: a multi-centre italian experience in real life. J Eur Acad Dermatol Venereol 2020; 34:e468-e470. [PMID: 32181535 DOI: 10.1111/jdv.16376] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2020] [Revised: 03/03/2020] [Accepted: 03/10/2020] [Indexed: 11/28/2022]
Affiliation(s)
- F Filippi
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
| | - G Odorici
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| | - A Conti
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy
| | - V Di Lernia
- Dermatology Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy
| | - S Di Nuzzo
- Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - M A Chessa
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
| | - M Corazza
- Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - A Patrizi
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
| | - F Bardazzi
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
| |
Collapse
|
24
|
Indovina I, Conti A, Lacquaniti F, Staab JP, Passamonti L, Toschi N. Reduced betweenness centrality of a sensory-motor vestibular network in subclinical agoraphobia. Annu Int Conf IEEE Eng Med Biol Soc 2020; 2019:4342-4345. [PMID: 31946829 DOI: 10.1109/embc.2019.8857332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Agoraphobic patients feel dizzy in crowded open spaces and respond to this symptom with excessive fear and avoidance. These clinical features show great similitude with the newly defined syndrome of persistent postural perceptual dizziness (PPPD). Patients with PPPD show decreased activity and connectivity in regions of the vestibular cortex. Due to the great overlap between these two conditions, we hypothesized that individuals with sub-clinical agoraphobia would show reduction in the connectivity features of these regions. We selected a group of healthy individuals from the Human Connectome Project that self-reported agoraphobia episodes, and compared it with a control group. We accurately matched the two groups for psychological measures and personality traits in order to study the neural correlates of vestibular symptoms independently of possible psychiatric vulnerabilities. We found that the agoraphobia group showed reduced betweenness centrality of a network encompassing key regions of the vestibular cortex. Dysfunctions of the vestibular cortex may explain the dizziness symptom for a disorder previously labelled as psychogenic.
Collapse
|
25
|
Conti A, Bini G, Renzi N, Bogazzi IC, Mazzucchelli M, Covelli A, Catarzi S, Lencioni AM, Genovesi M, Pisani N, Cipriano A, Ghiadoni L. P657Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Objective
To evaluate rates of major bleeding (mBleed) associated with anticoagulant treatments in patients (pts) with age ≥75 years (y), referred to hospital in northwest Tuscany.
Methods
We analysed 4-y survey; 302,687 visits; catchment area 197,722 inhabitants, of whom 15,267 on Warfarin (W) and 10,397 on direct oral anticoagulants (DOACs). DOACs were available in the catchment area since 4 y (dabigatran and rivaroxaban), 3 y (apixaban), and 2 y (edoxaban). Overall, 3,373 pts received dabigatran, 4,046 rivaroxaban, 2,141 apixaban, and 839 edoxaban. Pts with hemorrhage were submitted to propensity score matching for mBleed and stratified according to age ≥75 y, and W or DOACs. Primary endpoint was one-month death in pts with age ≥75 y.
Results
Out of 1,919 mBleed enrolled, those of pts aged ≥75 y were 1,127 (59%) versus (vs) 792 (41%) aged <75 y, with 77 (4.0%) one-month death vs 20 (1.0%), respectively; p<0.0001.
Patients on W showed higher rate of mBleed (n=175; 9.1%) compared to DOACs (n=53; 2.8%); p<0.0001. One-month death accounted for 14 (0.7%) vs 1 (0.1%), respectively; p=0.0019. Pts aged ≥75 years were more likely to show female gender and comorbidities including atrial fibrillation; p<0.01. Among DOACs, edoxaban presented the lowest absolute rate of hospital admission for mBleed and dabigatran the highest, although without statistical differences within DOACs (p=0.6454). Interestingly, in the subset of pts aged ≥75 y, within DOACs, we found no statistical difference in one-month mortality, although edoxaban showed one death due to brain mBleed; conversely, we found statistical significance in rate of mBleed. Indeed, edoxaban vs dabigatran showed p=0.0008, edoxaban vs apixaban p=0.0242, edoxaban vs rivaroxaban p=0.0058, apixaban vs rivaroxaban p=0.7093, apixaban vs dabigatran p=0.2279, rivaroxaban vs dabigatran p=0.5087.
Warfarin or DOACs and outcomes Major Bleeding (pts ≥75 y) p value versus pts <75 y p value within group One-month death (pts ≥75 y) p value versus pts <75 y p value within group n=1,127 n=77 Warfarin 175 (9.1%) 0.0001 <0.0001 14 (1.2%) 0.514 0.0019 DOACS 53 (2.8%) 0.0001 1 (0.1%) 0.256 Dabigatran 21 (1.1%) 0.026 0.0088 0 (0%) 0.391 0.8012 Rivaroxaban 16 (0.8%) 0.121 0 (0%) 0.619 Apixaban 13 (0.7%) 0.033 0 (0%) 1 Edoxaban 3 (0.2%) 0.647 1 (0.1%) 0.191 Patients: pts; direct oral anticoagulants: DOACs; p value Yates' correction: p value.
Patients with age >75 years and bleeding
Conclusion
In pts with age ≥75 y, rate of mBleed and short-term mortality were significantly higher than in pts aged <75 y In those pts, DOACs showed significantly lower rate of mBleed, and short-term death. Within DOACs, edoxaban was more likely to show lower rate of mBleed.
Collapse
Affiliation(s)
- A Conti
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - G Bini
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - N Renzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - I C Bogazzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - M Mazzucchelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A Covelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - S Catarzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A M Lencioni
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - M Genovesi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - N Pisani
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A Cipriano
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| | - L Ghiadoni
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| |
Collapse
|
26
|
Conti A, Renzi N, Bini G, Covelli A, Mazzucchelli M, Bigazzi IC, Lencioni AM, Bertolini L, Giusti L, Pennati P, Cipriano A, Ghiadoni L. P4636Major gastrointestinal haemorrhage of patients with ongoing anticoagulants presented to the emergency department of a community hospital: four-year survey. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Objective
To look for outcomes of patients (pts) with major gastrointestinal haemorrhage (mGIH) and ongoing anticoagulants out of four-year survey of community hospital with catchment area 197,722 inhabitants, of whom 15,267 with Warfarin (W) and 10,397 with direct oral anticoagulants (DOACs). DOACs were available for prescription in the catchment area since 4 years (dabigatran and rivaroxaban), 3 years (apixaban), and 2 years (edoxaban).
Methods
Haemorrhage (n=1,919) were submitted to propensity score matching for major bleeding; mGIH were enrolled and stratified according to ongoing W or DOACs. Primary endpoint was one-month death.
Results
Out of 476 mGIH, 73 pts received anticoagulants; 22 DOACs and 51 W; p=0.0006. Of note mGIH on W accounted for 2.7% (51/1,919) per year of pts, and 0.08% (51/15,267) of the catchment area. Conversely, mGIH on DOACs accounted as follows: dabigatran (n=10/476) 0.53%, rivaroxaban (n=6/476) 0.32%, apixaban (n=5/476) 0.35%, and edoxaban (n=1/476) 0.11% per year of pts; p=0.117. Rate of mGIH and DOACs versus (vs) rate of mGIH and W as follows: less than (−) 5 fold (2.7x100/0.53) of dabigatran vs W, p=0.004; −8 fold (2.7x100/0.32) of rivaroxaban vs W, p=0.0002; −7 fold (2.7x100/0.35) of apixaban vs W; p=0.ehz745.10188, and −25 fold (2.7x100/0.11) of edoxaban vs W; p=0.ehz745.101801. However no difference versus the catchment area per year (0.723): 0.07% (10/3,373) dabigatran, 0.04% (6/4,046) rivaroxaban, 0.08% (5/2,141) apixaban, 0.06% (1/839) edoxaban.
Overall, one-month death accounted for 10/476 (2.1%). Of note 236 mGI were from the upper tract and 240 from the lower tract. Among upper tract, 10 pts received DOACs (4 dabigatran, 4 rivaroxaban, 2 apixaban, and 0 edoxaban) and 21 received W. One-month death was 0/10 DOACs versus 1/21 W, p=0.483. Among lower tract, 12 pts received DOACs (6 dabigatran, 2 rivaroxaban, 3 apixaban, and 1 edoxaban) and 30 pts received W; one-month death was 0 for every groop. Anticoagulant reversal treatment was given to 6/22 (27%) pts with DOACs versus 18/51 (35%) with W, p=0.014; transfusion to 6/22 (27%) versus 11/51 (22%), respectively, p=0.306; admission 19/22 (86%) versus 42/51 (82%), respectively, p=0.004. Sensitivity/specificity ratio of variables and biomarkers for aggressive pharmacological approach were obtained by area under ROC curve (AUC) >0.50. PTT value >37 sec (AUC 0.57) showed sensitivity 15%, specificity 90%; INR value >1.4 (0.50), sens 15%, spec 80%. In addition, warfarin (0.49) sens 15%, spec 80%; age ≥75 years (0.48) sen 60%, spec 40%.
Gastrointestinal bleeding: flow-chart.
Conclusion
Out of four-year survey, pts with ongoing DOACs were less likely to have mGIH when compared to W.
Patients with W were more likely to receive reversal tratment; pts with DOACs were more likely to undergo admission. Short-term mortality of pts with W was higher than DOACs. Aggressive pharmacological approach should be driven by PTT, INR, ongoing warfarin, and older age.
Collapse
Affiliation(s)
- A Conti
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - N Renzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - G Bini
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A Covelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - M Mazzucchelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - I C Bigazzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A M Lencioni
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - L Bertolini
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - L Giusti
- University of Genoa, Top Master School of Nursing, Genoa, Italy
| | - P Pennati
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| | - A Cipriano
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| | - L Ghiadoni
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| |
Collapse
|
27
|
Odorici G, Lasagni C, Bigi L, Pellacani G, Conti A. A real‐life experience of psoriatic patients with history of cancer treated with biological drugs. J Eur Acad Dermatol Venereol 2019; 33:e453-e455. [DOI: 10.1111/jdv.15775] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- G. Odorici
- Dermatology Unit Department of Surgical, Medical, Dental and Morphological Sciences with Interest Transplant, Oncological and Regenerative Medicine University of Modena and Reggio Emilia Modena Italy
| | - C. Lasagni
- Dermatology Unit Department of Surgical, Medical, Dental and Morphological Sciences with Interest Transplant, Oncological and Regenerative Medicine University of Modena and Reggio Emilia Modena Italy
| | - L. Bigi
- Dermatology Unit Department of Surgical, Medical, Dental and Morphological Sciences with Interest Transplant, Oncological and Regenerative Medicine University of Modena and Reggio Emilia Modena Italy
| | - G. Pellacani
- Dermatology Unit Department of Surgical, Medical, Dental and Morphological Sciences with Interest Transplant, Oncological and Regenerative Medicine University of Modena and Reggio Emilia Modena Italy
| | - A. Conti
- Dermatology Unit Department of Surgical, Medical, Dental and Morphological Sciences with Interest Transplant, Oncological and Regenerative Medicine University of Modena and Reggio Emilia Modena Italy
| |
Collapse
|
28
|
Conti A, Peccerillo F, Amerio P, Balato A, Bardazzi F, Bianchi L, Burlando M, Cannavò S, Chiricozzi A, Dapavo P, De Simone C, Fargnoli M, Gambardella A, Gisondi P, Malagoli P, Malara G, Mugheddu C, Offidani A, Piaserico S, Prignano F, Stingeni L, Pellacani G. Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. Br J Dermatol 2019; 180:1547-1548. [DOI: 10.1111/bjd.17580] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- A. Conti
- Department of Dermatology University of Modena and Reggio Emilia Modena Italy
| | - F. Peccerillo
- Department of Dermatology University of Modena and Reggio Emilia Modena Italy
| | - P. Amerio
- Department of Medicine and Aging Science Dermatologic Clinic, G. D'Annunzio University Chieti Italy
| | - A. Balato
- Department of Dermatology University of Naples Federico II Naples Italy
| | - F. Bardazzi
- Department of Specialized, Clinical and Experimental Medicine Division of Dermatology University of Bologna Bologna Italy
| | - L. Bianchi
- Department of Dermatology University of Rome Tor Vergata Rome Italy
| | - M. Burlando
- Section of Dermatology University of Genoa San Martino Polyclinic Hospital Genoa Italy
| | - S.P. Cannavò
- Department of Clinical and Experimental Medicine – Dermatology University of Messina Messina Italy
| | - A. Chiricozzi
- Department of Dermatology University of Pisa Pisa Italy
| | - P. Dapavo
- Department of Biomedical Science and Human Oncology Second Dermatologic Clinic University of Turin Turin Italy
| | - C. De Simone
- Department of Dermatology Catholic University of the Sacred Heart Rome Italy
| | - M.C. Fargnoli
- Department of Dermatology University of L'Aquila L'Aquila Italy
| | | | - P. Gisondi
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| | - P. Malagoli
- Dermatology Unit Azienda Ospedaliera San Donato Milanese Milan Italy
| | - G. Malara
- Dermatology Department Grande Ospedale Metropolitano Bianchi Melacrino Morelli 89124 Reggio Calabria Italy
| | - C. Mugheddu
- Department of Medical Sciences and Public Health Section of Dermatology University of Cagliari Cagliari Italy
| | - A.M. Offidani
- Department of Clinical and Molecular Sciences Dermatology Unit Polytechnic Marche University Ancona Italy
| | - S. Piaserico
- Department of Dermatology University of Padua Padova Italy
| | - F. Prignano
- Department of Dermatology University of Florence Firenze Italy
| | - L. Stingeni
- Department of Medicine Section of Clinical, Allergological and Venereological Dermatology University of Perugia Perugia Italy
| | - G. Pellacani
- Department of Dermatology University of Modena and Reggio Emilia Modena Italy
| |
Collapse
|
29
|
Odorici G, Di Lernia V, Bardazzi F, Magnano M, Di Nuzzo S, Cortelazzi C, Lasagni C, Bigi L, Corazza M, Pellacani G, Conti A. Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-centre experience. J Eur Acad Dermatol Venereol 2019; 33:e374-e377. [PMID: 31077634 DOI: 10.1111/jdv.15671] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Affiliation(s)
- G Odorici
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, 41124, Italy
| | - V Di Lernia
- Dermatology Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, 42123, Italy
| | - F Bardazzi
- Department of Specialized, Division of Dermatology, Clinical and Experimental Medicine, University of Bologna, Bologna, 40138, Italy
| | - M Magnano
- Department of Specialized, Division of Dermatology, Clinical and Experimental Medicine, University of Bologna, Bologna, 40138, Italy
| | - S Di Nuzzo
- Dermatology, Department of Medicine and Surgery, University of Parma, Parma, 43126, Italy
| | - C Cortelazzi
- Dermatology, Department of Medicine and Surgery, University of Parma, Parma, 43126, Italy
| | - C Lasagni
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, 41124, Italy
| | - L Bigi
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, 41124, Italy
| | - M Corazza
- Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, 44124, Italy
| | - G Pellacani
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, 41124, Italy
| | - A Conti
- Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, 41124, Italy
| |
Collapse
|
30
|
Paladini D, Donarini G, Conti A, Costanza De Angelis L, Witte MH, Genesio R, Bernas M, Bellini T, Boccardo F, Ramenghi LA, Bellini C. EARLY FETAL HYDROPIC CHANGES ARE ASSOCIATED WITH MODERATE DILATATION OF THE BRAIN VENTRICULAR SYSTEM: A CLUE TO A POSSIBLE LINK BETWEEN CERVICAL LYMPHATIC ENGORGEMENT AND VENTRICULAR DILATATION? Lymphology 2019. [DOI: 10.2458/lymph.4620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The aim of this study is to assess whether early cervical lymphatic obstruction is associated with a sonographically detectable dilatation of the ventricular system in the 1st trimester of pregnancy. In particular, the objective is to assess whether fetuses with non-immune hydrops fetalis (NIHF), cystic hygroma, or enlarged nuchal translucency (NT) have a greater atrial width/biparietal diameter (AW/BPD) ratio than normal at time of the combined first trimester screening scan. This retrospective study included 96 first trimester fetuses (33 normal and 63 with various degree of cervical lymphatic engorgement). Inclusion criteria were CRL in the 45-84 mm range and availability of one or more three-dimensional volume datasets of the fetal head, acquired from the BPD plane. Each three-dimensional volume dataset was opened and multiplanar correlation employed to align the three orthogonal planes. The ratio between the atrial width and the BPD (AW/BPD ratio) was used to evaluate the possible presence of increased amount of cerebrospinal fluid. Abnormal cases were placed into 4 categories: 1)enlarged non-septated NT 2.5-3.9 mm, no hydrops; 2) grossly enlarged non-septated NT/ edema >3.9 mm; 3) cystic hygroma and/or NIHF; 4) major anomalies with NT <2.5 mm. Presence of dilatation of the latero-cervical jugular lymphatic sacs, karyotype and presence of congenital anomalies were also recorded. The One-way ANOVA test was used to compare means. Intra- and inter-observer variability were also assessed. The AW/BPD ratio was found to be significantly higher in fetuses with grossly enlarged NT/nuchal edema and NIHF/septated cystic hygroma than in normal (p <0.05 and p <0.01, respectively). Also, the AW/BPD ratio was significantly higher in NIHF/septated cystic hygroma than in enlarged NT 2.5-3.9 mm (p <0.05). In case of enlarged NT (2.5-3.9 mm), the AW/BPD ratio is significantly higher in presence of JLS (p <0.01). At the end of the first trimester, presence of cervical lymphatic engorgement, in terms of grossly enlarged NT, nuchaledema, septated cystic hygroma, and NIHF, is statistically associated with a moderate dilatation of the ventricular system. Of note, among fetuses with moderately enlarged NT, those with evidence of dilatation of the JLS show a statistically significant increase in the AW/BPD ratio.
Collapse
|
31
|
Ortolani O, Conti A, Chan YK, Sie MY, Ong GSY. Comparison of Propofol Consumption and Recovery Time in Caucasians from Italy, with Chinese, Malays and Indians from Malaysia. Anaesth Intensive Care 2019; 32:250-5. [PMID: 15957725 DOI: 10.1177/0310057x0403200215] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Differences in sensitivity to anaesthetic drugs may exist among different ethnic groups. Allelic variants for drug metabolizing isoenzymes and pharmacokinetic differences may account for a variable response to some anaesthetic drugs. This study was designed to compare propofol consumption and recovery characteristics in four ethnic groups: Chinese, Malays, and Indians in Malaysia and Caucasians in Italy. Patients undergoing total intravenous anaesthesia with propofol and fentanyl were evaluated for propofol consumption and recovery time. The Bispectral Index (BIS) was used to maintain the same anaesthesia depth in all patients. The BIS value, the response to verbal stimuli and eye-opening time were used to assess recovery. After propofol discontinuation the BIS values returned to baseline in 11±4.2 min for Caucasians, in 12.5±5.1 min for Chinese, 15.9±6.3 min for Malays and 22.1±8.1 for Indians. Time to eye-opening was 11.63±4.2 min in Caucasians, 13.23±4.9 min in Chinese, 16.97±5.2 min in Malays and 22.3±6.6 min in Indians. The propofol consumption was significantly lower in Indians compared to the other three groups (P<0.01). The recovery of Indians was much slower compared to Chinese, Malays and Caucasians. The recovery time of Malays is significantly slower compared to Chinese and Caucasians. Differences in propofol consumption and recovery time were not significant between Chinese and Caucasians, but the ratio recovery time/propofol consumption was significantly lower in Caucasians compared to all the other groups.
Collapse
Affiliation(s)
- O Ortolani
- University of Florence, Dipartimento di Area Critica Medico Chirurgica, Sezione di Anestesia e Rianimazione, Unita 'Anestesia e Rianimazione Sperimentali, University of Naples "Federico II", Naples, Italy
| | | | | | | | | |
Collapse
|
32
|
Paladini D, Donarini G, Conti A, Constanza De Angelis L, Witte MH, Genesio R, Bernas M, Bellini T, Boccardo F, Ramenghi LA, Bellini C. Early fetal hydropic changes are associated with moderate dilatation of the brain ventricular system: A clue to a possible link between cervical lymphatic engorgement and ventricular dilatation? Lymphology 2019; 52:11-17. [PMID: 31119910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The aim of this study is to assess whether early cervical lymphatic obstruction is associated with a sonographically detectable dilatation of the ventricular system in the 1st trimester of pregnancy. In particular, the objective is to assess whether fetuses with non-immune hydrops fetalis (NIHF), cystic hygroma, or enlarged nuchal translucency (NT) have a greater atrial width/biparietal diameter (AW/BPD) ratio than normal at time of the combined first trimester screening scan. This retrospective study included 96 first trimester fetuses (33 normal and 63 with various degree of cervical lymphatic engorgement). Inclusion criteria were CRL in the 45-84 mm range and availability of one or more three-dimensional volume datasets of the fetal head, acquired from the BPD plane. Each three-dimensional volume dataset was opened and multiplanar correlation employed to align the three orthogonal planes. The ratio between the atrial width and the BPD (AW/BPD ratio) was used to evaluate the possible presence of increased amount of cerebrospinal fluid. Abnormal cases were placed into 4 categories: 1) enlarged non-septated NT 2.5-3.9 mm, no hydrops; 2) grossly enlarged non-septated NT / edema >3.9 mm; 3) cystic hygroma and/ or NIHF; 4) major anomalies with NT <2.5 mm. Presence of dilatation of the laterocervical jugular lymphatic sacs, karyotype and presence of congenital anomalies were also recorded. The One-way ANOVA test was used to compare means. Intra- and inter-observer variability were also assessed. The AW/BPD ratio was found to be significantly higher in fetuses with grossly enlarged NT/nuchal edema and NIHF/septated cystic hygroma than in normal (p <0.05 and p <0.01, respectively). Also, the AW/BPD ratio was significantly higher in NIHF/septated cystic hygroma than in enlarged NT 2.5-3.9 mm (p <0.05). In case of enlarged NT (2.5-3.9 mm), the AW/BPD ratio is significantly higher in presence of JLS (p <0.01). At the end of the first trimester, presence of cervical lymphatic engorgement, in terms of grossly enlarged NT, nuchal edema, septated cystic hygroma, and NIHF, is statistically associated with a moderate dilatation of the ventricular system. Of note, among fetuses with moderately enlarged NT, those with evidence of dilatation of the JLS show a statistically significant increase in the AW/BPD ratio.
Collapse
Affiliation(s)
- D Paladini
- Fetal Medicine and Surgery Unit, Gaslini Institute, Genoa, Italy
| | - G Donarini
- Fetal Medicine and Surgery Unit, Gaslini Institute, Genoa, Italy
| | - A Conti
- Cytogenetics, University Federico II of Naples, Italy
| | - L Constanza De Angelis
- Department of Mother and Child, Neonatal Intensive Care Unit, Gaslini Institute, Genova, Italy
| | - M H Witte
- Department of Surgery, University of Arizona College of Medicine, Tucson, AZ
| | - R Genesio
- Department of Mother and Child, Neonatal Intensive Care Unit, Gaslini Institute, Genova, Italy
| | - M Bernas
- Department of Medical Education, TCU and UNTHSC School of Medicine, Fort Worth, TX, USA
| | - T Bellini
- Department of Mother and Child, Neonatal Intensive Care Unit, Gaslini Institute, Genova, Italy
| | - F Boccardo
- Dept. of Surgery, University of Genova, Italy
| | - L A Ramenghi
- Department of Mother and Child, Neonatal Intensive Care Unit, Gaslini Institute, Genova, Italy
| | - C Bellini
- Department of Mother and Child, Neonatal Intensive Care Unit, Gaslini Institute, Genova, Italy
| |
Collapse
|
33
|
Gisondi P, Bianchi L, Calzavara‐Pinton P, Conti A, Chiricozzi A, Fimiani M, Pellegrino M, Giunta A, Prignano F, Tiberio R, Venturini M, Girolomoni G. Etanercept biosimilar
SB
4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry. Br J Dermatol 2018; 180:409-410. [DOI: 10.1111/bjd.17133] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- P. Gisondi
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| | - L. Bianchi
- Section of Dermatology University of Rome Tor Vergata Rome Italy
| | | | - A. Conti
- Department of Head and Neck Surgery Section of Dermatology Azienda Ospedaliero Universitaria Policlinico di Modena Modena Italy
| | - A. Chiricozzi
- Section of Dermatology University of Pisa Pisa Italy
| | - M. Fimiani
- Department of Medical Surgical and Neurological Science Section of Dermatology Siena University Hospital Siena Italy
| | - M. Pellegrino
- Department of Medical Surgical and Neurological Science Section of Dermatology Siena University Hospital Siena Italy
| | - A. Giunta
- Section of Dermatology University of Rome Tor Vergata Rome Italy
| | - F. Prignano
- Department of Surgery and Translational Medicine Section of Dermatology University of Florence Florence Italy
| | - R. Tiberio
- Section of Dermatology ‘Maggiore della Carità’ Hospital University of Eastern Piedmont ‘A. Avogadro’ Novara Italy
| | - M. Venturini
- Section of Dermatology University of Brescia Brescia Italy
| | - G. Girolomoni
- Department of Medicine Section of Dermatology and Venereology University of Verona Verona Italy
| |
Collapse
|
34
|
Conti A, Bianchi S, Renzi N, Catarzi S, Mazzucchelli M, Covelli A, Bini G, Finizola F, Bogazzi I, Cipriano A, Leorin M, Ghiadoni L. P6585Aging and outcomes of patients with major bleeding events with or without ongoing anticoagulants in real life. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Conti
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - S Bianchi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - N Renzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - S Catarzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - M Mazzucchelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A Covelli
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - G Bini
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - F Finizola
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - I Bogazzi
- North-West District Tuscany HealthCare, Apuane General Hospital, Emergency Department, Massa-Carrara, Italy
| | - A Cipriano
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| | - M Leorin
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| | - L Ghiadoni
- North-West District Tuscany HealthCare, Cisanello General Hospital and University of Pisa, Emergency Department, Pisa, Italy
| |
Collapse
|
35
|
Conti A, Luchini A, Benassi M, Magagnoli G, Pierini M, Leopardi MP, Quattrini I, Pollino S, Liotta L, Pazzaglia L. PO-485 Low abundance circulating proteins in giant cell tumours of bone. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.987] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
36
|
Ponti G, Maccaferri M, Manfredini M, Cotugno M, Pellacani G, Conti A, Micali S, Mandrioli M, Tomasi A. Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers. Med Hypotheses 2018; 114:69. [DOI: 10.1016/j.mehy.2018.02.034] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2018] [Accepted: 02/25/2018] [Indexed: 10/17/2022]
|
37
|
Majorini MT, Manenti G, Mano M, De Cecco L, Conti A, Pinciroli P, Fontanella E, Tagliabue E, Chiodoni C, Colombo MP, Delia D, Lecis D. cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells. Cell Death Differ 2018; 25:2147-2164. [PMID: 29674627 PMCID: PMC6262016 DOI: 10.1038/s41418-018-0100-0] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Revised: 03/01/2018] [Accepted: 03/12/2018] [Indexed: 12/26/2022] Open
Abstract
Inhibitor of apoptosis (IAP) proteins constitute a family of conserved molecules that regulate both apoptosis and receptor signaling. They are often deregulated in cancer cells and represent potential targets for therapy. In our work, we investigated the effect of IAP inhibition in vivo to identify novel downstream genes expressed in an IAP-dependent manner that could contribute to cancer aggressiveness. To this end, immunocompromised mice engrafted subcutaneously with the triple-negative breast cancer MDA-MB231 cell line were treated with SM83, a Smac mimetic that acts as a pan-IAP inhibitor, and tumor nodules were profiled for gene expression. SM83 reduced the expression of Snai2, an epithelial-to-mesenchymal transition factor often associated with increased stem-like properties and metastatic potential especially in breast cancer cells. By testing several breast cancer cell lines, we demonstrated that Snai2 downregulation prevents cell motility and that its expression is promoted by cIAP1. In fact, the chemical or genetic inhibition of cIAP1 blocked epidermal growth factor receptor (EGFR)-dependent activation of the mitogen-activated protein kinase (MAPK) pathway and caused the reduction of Snai2 transcription levels. In a number of breast cancer cell lines, cIAP1 depletion also resulted in a reduction of EGFR protein levels which derived from the decrease of its gene transcription, though, paradoxically, the silencing of cIAP1 promoted EGFR protein stability rather than its degradation. Finally, we provided evidence that IAP inhibition displays an anti-tumor and anti-metastasis effect in vivo. In conclusion, our work indicates that IAP-targeted therapy could contribute to EGFR inhibition and to the reduction of its downstream mediators. This approach could be particularly effective in tumors characterized by high levels of EGFR and Snai2, such as triple-negative breast cancer.
Collapse
Affiliation(s)
- Maria Teresa Majorini
- Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Mechanisms of Cell Cycle Control Unit, Milan, Italy
| | - Giacomo Manenti
- Department of Predictive & Preventive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - Miguel Mano
- Functional Genomics and RNA-Based Therapeutics Laboratory, Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, 3060-197, Portugal
| | - Loris De Cecco
- Functional Genomics and Bioinformatics Core Facility, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - Annalisa Conti
- Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Mechanisms of Cell Cycle Control Unit, Milan, Italy.,Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia (IIT), Milan, Italy
| | - Patrizia Pinciroli
- Functional Genomics and Bioinformatics Core Facility, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - Enrico Fontanella
- Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Mechanisms of Cell Cycle Control Unit, Milan, Italy
| | - Elda Tagliabue
- Department of Experimental Oncology & Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Targeting Unit, Milan, Italy
| | - Claudia Chiodoni
- Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Immunology Unit, Milan, Italy
| | - Mario Paolo Colombo
- Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Immunology Unit, Milan, Italy
| | - Domenico Delia
- Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Mechanisms of Cell Cycle Control Unit, Milan, Italy
| | - Daniele Lecis
- Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Mechanisms of Cell Cycle Control Unit, Milan, Italy. .,Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Molecular Immunology Unit, Milan, Italy.
| |
Collapse
|
38
|
D'Andrea A, Gritti I, Nicoli P, Giorgio M, Doni M, Conti A, Bianchi V, Casoli L, Sabò A, Mironov A, Beznoussenko GV, Amati B. The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas. Oncotarget 2018; 7:72415-72430. [PMID: 27635472 PMCID: PMC5341918 DOI: 10.18632/oncotarget.11719] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2016] [Accepted: 08/25/2016] [Indexed: 12/12/2022] Open
Abstract
The oncogenic transcription factor Myc is required for the progression and maintenance of diverse tumors. This has led to the concept that Myc itself, Myc-activated gene products, or associated biological processes might constitute prime targets for cancer therapy. Here, we present an in vivo reverse-genetic screen targeting a set of 241 Myc-activated mRNAs in mouse B-cell lymphomas, unraveling a critical role for the mitochondrial ribosomal protein (MRP) Ptcd3 in tumor maintenance. Other MRP-coding genes were also up regulated in Myc-induced lymphoma, pointing to a coordinate activation of the mitochondrial translation machinery. Inhibition of mitochondrial translation with the antibiotic Tigecycline was synthetic-lethal with Myc activation, impaired respiratory activity and tumor cell survival in vitro, and significantly extended lifespan in lymphoma-bearing mice. We have thus identified a novel Myc-induced metabolic dependency that can be targeted by common antibiotics, opening new therapeutic perspectives in Myc-overexpressing tumors.
Collapse
Affiliation(s)
- Aleco D'Andrea
- Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
| | - Ilaria Gritti
- Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.,Present address: IRCCS San Raffaele, Functional Genomics of Cancer Unit, Division of Experimental Oncology, Milan, Italy
| | - Paola Nicoli
- Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
| | - Marco Giorgio
- Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
| | - Mirko Doni
- Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
| | - Annalisa Conti
- Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy
| | - Valerio Bianchi
- Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy.,Present address: Hubrecht Institute-KNAW & University Medical Center Utrecht, Uppsalalaan, Utrecht, The Netherlands
| | - Lucia Casoli
- Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy
| | - Arianna Sabò
- Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy
| | - Alexandre Mironov
- The Institute of Molecular Oncology of the Italian Foundation for Cancer Research, Milan, Italy
| | - Galina V Beznoussenko
- The Institute of Molecular Oncology of the Italian Foundation for Cancer Research, Milan, Italy
| | - Bruno Amati
- Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.,Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy
| |
Collapse
|
39
|
Magnano M, Loi C, Patrizi A, Sgubbi P, Balestri R, Rech G, Tasin L, Girardelli CR, Conti A, Odorici G, Campanati A, Offidani AM, Bardazzi F. Secukinumab in multi-failure psoriatic patients: the last hope? J DERMATOL TREAT 2018; 29:583-585. [DOI: 10.1080/09546634.2018.1427206] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- M. Magnano
- Department of Specialized, Diagnostic and Experimental Medicine University of Bologna, Italy
| | - C. Loi
- Department of Specialized, Diagnostic and Experimental Medicine University of Bologna, Italy
| | - A. Patrizi
- Department of Specialized, Diagnostic and Experimental Medicine University of Bologna, Italy
| | - P. Sgubbi
- Department of Specialized, Diagnostic and Experimental Medicine University of Bologna, Italy
| | - R. Balestri
- Dermatology Division, Multizonale Santa Chiara Hospital, Trento, Italy
| | - G. Rech
- Dermatology Division, Multizonale Santa Chiara Hospital, Trento, Italy
| | - L Tasin
- Dermatology Division, Multizonale Santa Chiara Hospital, Trento, Italy
| | - C. R. Girardelli
- Dermatology Division, Multizonale Santa Chiara Hospital, Trento, Italy
| | - A. Conti
- Dermatology Unit, United Hospital of Ancona Polytechnic Marche University, Ancona, Italy
| | - G. Odorici
- Dermatology Unit, United Hospital of Ancona Polytechnic Marche University, Ancona, Italy
| | - A. Campanati
- Psoriasis Outpatient Clinic of the Polyclinic University Hospital, Modena, Italy
| | - A. M. Offidani
- Psoriasis Outpatient Clinic of the Polyclinic University Hospital, Modena, Italy
| | - F. Bardazzi
- Department of Specialized, Diagnostic and Experimental Medicine University of Bologna, Italy
| |
Collapse
|
40
|
Gisondi P, Altomare G, Ayala F, Conti A, Dapavo P, De Simone C, Foti C, Idolazzi L, Lubrano E, Malara G, Marchesoni A, Olivieri I, Parodi A, Peris K, Piaserico S, Salvarani C, Scarpa R, Girolomoni G. Consensus on the management of patients with psoriatic arthritis in a dermatology setting. J Eur Acad Dermatol Venereol 2018; 32:515-528. [PMID: 29220551 DOI: 10.1111/jdv.14741] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2017] [Accepted: 11/22/2017] [Indexed: 12/13/2022]
Abstract
BACKGROUND Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis (PsO). Early diagnosis and prompt therapeutic intervention are crucial for limiting PsA progression and prevention of disability. Dermatologists are in a privileged position to detect early PsA. The management of patients with PsA in the dermatology setting is widely variable. OBJECTIVE To provide practical recommendations for the management of patients with PsA in the dermatology setting including early diagnosis and treatment. METHODS A consensus document was written by an expert panel composed by dermatologists (n = 12) and rheumatologists (n = 6). Eleven highly relevant questions were selected and elaborated with answers/statements based on a narrative literature review. The resulting document was discussed in a face-to-face meeting adopting a nominal group technique to reach consensus (i.e. 100% agreement) using the Delphi method. RESULTS A consensus was achieved in defining the following: the clinical characteristics differentiating inflammatory and non-inflammatory signs and symptoms of joint disease; the most important differential diagnoses of PsA in clinical practice; the most useful screening questionnaires, serum laboratory tests and imaging techniques for the detection of early PsA; the criteria for dermatologist to refer patients with PsO to rheumatologist; the criteria for the diagnosis of PsA; the selection of the indices that the dermatologist could use for measuring the activity and severity of PsA in clinical practice; when systemic steroids and/or intra-articular steroid injections are indicated in the treatment of PsA. Finally, systemic treatments including synthetic and biologic disease-modifying antirheumatic drugs to be considered for the treatment of PsA have been reported. CONCLUSIONS The implementations of these practical recommendations could be very helpful for the management of patients with PsA in the dermatology setting including early diagnosis and treatment.
Collapse
Affiliation(s)
- P Gisondi
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| | - G Altomare
- I.R.C.C.S Istituto Ortopedico Galeazzi, Division of Dermatology and Venereology, University of Milan, Milan, Italy
| | - F Ayala
- Department of Dermatology, University of Naples Federico II, Naples, Italy
| | - A Conti
- Department of Head and Neck Surgery, Section of Dermatology, Azienda Ospedaliero Universitaria Policlinico di Modena, Modena, Italy
| | - P Dapavo
- Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy
| | - C De Simone
- Dermatology Department, Catholic University of the Sacred Heart, Rome, Italy
| | - C Foti
- Department of Biomedical Science and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy
| | - L Idolazzi
- Department of Medicine, Section of Rheumatology, University of Verona, Verona, Italy
| | - E Lubrano
- Dipartimento di Medicina e Scienze della Salute "Vincenzo Tiberio", Università degli Studi del Molise, Campobasso, Italy
| | - G Malara
- Unit of Dermatology, Azienda Ospedaliera Papardo, Messina, Italy
| | - A Marchesoni
- Department of Rheumatology, ASST Gaetano Pini-CTO, Milano, Italy
| | - I Olivieri
- Division of Rheumatology, Azienda Ospedaliera San Carlo, Potenza, Italy
| | - A Parodi
- Section of Dermatology, University of Genoa, Genoa, Italy
| | - K Peris
- Dermatology Department, Catholic University of the Sacred Heart, Rome, Italy
| | - S Piaserico
- Department of Medicine, Section of Dermatology, University of Padua, Padua, Italy
| | - C Salvarani
- Division of Rheumatology, Azienda USL-IRCCS di Reggio Emilia, University of Modena and Reggio Emilia, Modena, Reggio Emilia, Italy
| | - R Scarpa
- Department of Medicine, Section of Rheumatology, University of Naples Federico II, Naples, Italy
| | - G Girolomoni
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| |
Collapse
|
41
|
Serra A, Caltabiano R, Giorlandino A, Musumeci A, Conti A, Zanghì G, Maniaci A, Cocuzza S. Nasal metastasis as the first manifestation of a metachronous bilateral renal cell carcinoma. Pathologica 2017; 109:421-425. [PMID: 29449739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023] Open
Abstract
Renal cell carcinoma is one of the most common tumours to spread by extranodal metastases to the head and neck. Metastatic renal cell carcinoma to the head and neck area has been demonstrated mostly in the paranasal sinuses, parotid gland, the mandible, larynx and hypopharinx. Renal cell carcinoma should be excluded whenever a metastatic lesion is encountered in the head and neck area, even if the metastatic lesion is the first clinical presentation. The diagnosis of metastatic RCC should be suspected in any patient with even a remote history of renal cell carcinoma. We report a case of 79 year old woman with recurrent episodes of rhinorrhea, headache, hyposmia and monolateral right epistaxis, with a history of RCC. We describe RCC nasal metastases in a metachronous bilateral neoplasm, in which a second occult lesion debuted with a homolateral nasal metastases, ten years after left nephrectomy.
Collapse
Affiliation(s)
- A Serra
- ENT Department of University of Catania, Italy
| | - R Caltabiano
- Department G.F. Ingrassia, Section of Anatomic Pathology, University of Catania, Italy
| | - A Giorlandino
- Department G.F. Ingrassia, Section of Anatomic Pathology, University of Catania, Italy
| | - A Musumeci
- Department of Radiology, AOU "Policlinico-Vittorio Emanuele", University of Catania, Italy
| | - A Conti
- ENT Department of University of Catania, Italy
| | - G Zanghì
- Department of Surgery, University of Catania, Italy
| | - A Maniaci
- ENT Department of University of Catania, Italy
| | - S Cocuzza
- ENT Department of University of Catania, Italy
| |
Collapse
|
42
|
Gisondi P, Bianchi L, Conti A, Dapavo P, Malagoli P, Piaserico S, Savoia F, Prignano F, Girolomoni G. Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry. Br J Dermatol 2017; 177:e325-e326. [PMID: 28498543 DOI: 10.1111/bjd.15659] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- P Gisondi
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| | - L Bianchi
- Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
| | - A Conti
- Department of Head and Neck Surgery, Section of Dermatology, Azienda Ospedaliero Universitaria Policlinico di Modena, Modena, Italy
| | - P Dapavo
- Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy
| | - P Malagoli
- Section of Dermatology, I.R.C.C.S. Policlinico San Donato, Milan, Italy
| | - S Piaserico
- Department of Medicine, Section of Dermatology, University of Padua, Padua, Italy
| | - F Savoia
- Dermatology, Ospedale 'Umberto I' di Lugo, Ravenna, Italy
| | - F Prignano
- Department of Surgery and Translational Medicine, Section of Dermatology, University of Florence, Florence, Italy
| | - G Girolomoni
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| |
Collapse
|
43
|
Odorici G, Losi A, Ciardo S, Pellacani G, Conti A. Non-invasive evaluation of Secukinumab efficacy in severe plaque psoriasis with confocal microscopy and optical coherence tomography: A case report. Skin Res Technol 2017; 24:160-162. [PMID: 29067742 DOI: 10.1111/srt.12409] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/10/2017] [Indexed: 11/29/2022]
Affiliation(s)
- G Odorici
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - A Losi
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - S Ciardo
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - G Pellacani
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - A Conti
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
44
|
Sinibaldi R, Conti A, Sinjari B, Spadone S, Pecci R, Palombo M, Komlev VS, Ortore MG, Tromba G, Capuani S, Guidotti R, De Luca F, Caputi S, Traini T, Della Penna S. Multimodal-3D imaging based on μMRI and μCT techniques bridges the gap with histology in visualization of the bone regeneration process. J Tissue Eng Regen Med 2017; 12:750-761. [PMID: 28593731 DOI: 10.1002/term.2494] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2016] [Revised: 04/23/2017] [Accepted: 06/05/2017] [Indexed: 01/05/2023]
Abstract
Bone repair/regeneration is usually investigated through X-ray computed microtomography (μCT) supported by histology of extracted samples, to analyse biomaterial structure and new bone formation processes. Magnetic resonance imaging (μMRI) shows a richer tissue contrast than μCT, despite at lower resolution, and could be combined with μCT in the perspective of conducting non-destructive 3D investigations of bone. A pipeline designed to combine μMRI and μCT images of bone samples is here described and applied on samples of extracted human jawbone core following bone graft. We optimized the coregistration procedure between μCT and μMRI images to avoid bias due to the different resolutions and contrasts. Furthermore, we used an Adaptive Multivariate Clustering, grouping homologous voxels in the coregistered images, to visualize different tissue types within a fused 3D metastructure. The tissue grouping matched the 2D histology applied only on 1 slice, thus extending the histology labelling in 3D. Specifically, in all samples, we could separate and map 2 types of regenerated bone, calcified tissue, soft tissues, and/or fat and marrow space. Remarkably, μMRI and μCT alone were not able to separate the 2 types of regenerated bone. Finally, we computed volumes of each tissue in the 3D metastructures, which might be exploited by quantitative simulation. The 3D metastructure obtained through our pipeline represents a first step to bridge the gap between the quality of information obtained from 2D optical microscopy and the 3D mapping of the bone tissue heterogeneity and could allow researchers and clinicians to non-destructively characterize and follow-up bone regeneration.
Collapse
Affiliation(s)
- R Sinibaldi
- Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy
- Multimodal3D s.r.l., Rome, Italy
| | - A Conti
- Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy
| | - B Sinjari
- Department of Medical and Oral Sciences and Biotechnologies, G. D'Annunzio University of Chieti and Pescara, Chieti, Italy
| | - S Spadone
- Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy
| | - R Pecci
- Department of Technologies and Health, Istituto Superiore di Sanità, Rome, Italy
| | - M Palombo
- Department of Physics, Sapienza University of Rome, Rome, Italy
- CEA/DSV/I2BM, MIRCen, Fontenay-aux-Roses, France
| | - V S Komlev
- A.A. Baikov Institute of Metallurgy and Materials Science, Russian Academy of Sciences, Moscow, Russian Federation
| | - M G Ortore
- Department of Life and Environmental Science, Marche Polytechnic University, Ancona, Italy
| | - G Tromba
- Elettra Sincrotrone Trieste, Trieste, Italy
| | - S Capuani
- CNR (Institute for Complex Systems) c/o Physics Department Sapienza University of Rome, Rome, Italy
| | - R Guidotti
- Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy
| | - F De Luca
- Department of Physics, Sapienza University of Rome, Rome, Italy
| | - S Caputi
- Department of Medical and Oral Sciences and Biotechnologies, G. D'Annunzio University of Chieti and Pescara, Chieti, Italy
| | - T Traini
- Department of Medical and Oral Sciences and Biotechnologies, G. D'Annunzio University of Chieti and Pescara, Chieti, Italy
| | - S Della Penna
- Department of Neuroscience, Imaging and Clinical Sciences, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy
- Institute for Advanced Biomedical Technologies, G. D'Annunzio University of Chieti-Pescara, Chieti, Italy
| |
Collapse
|
45
|
Serra A, Spinato G, Spinato R, Conti A, Licciardello L, Di Luca M, Campione G, Tonoli G, Politi D, Castro V, Maniaci A, Maiolino L, Cocuzza S. Multicenter prospective crossover study on new prosthetic opportunities in post-laryngectomy voice rehabilitation. J BIOL REG HOMEOS AG 2017; 31:803-809. [PMID: 28958139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The aim of this study was to assess the clinical experience of three Italian centers using the third generation Provox Vega prosthesis, in terms of device life and voice outcome, comparing the results with the second generation Provox 2 prosthesis in the same sample. A prospective multicenter crossover study was performed in three phases. In the first phase we performed a reassessment, for enrollment purposes, of patients who were categorized into four different groups [normal – group A; radio-treated – group B; gastroesophageal reflux disease (GERD) – group C; and elderly subjects – group D]. In the second and third phases, all patients were monitored for prosthetic device life and assessed for objective and subjective voice characteristics after introducing Provox 2 and Provox Vega prostheses. In patients with Provox 2 prosthesis, the mean life was 165 days in group A, 148 days in group B, 91 days in group C and 188 days in group D. In Provox Vega patients, mean in situ prosthesis life was 213 days in group A, 182 days in group B, 118 days in group C and 227 days in group D. The perceptual voice data showed a better rating across all parameters for the Provox Vega samples compared to those of Provox 2. In this paper, we report the first multicenter crossover study comparing different prosthetic models in the same patients, categorized in relation to different typologies of tracheoesophageal rehabilitative status. Result analyses confirmed an optimal stability of the Provox Vega compared to the Provox 2, in terms of device life and perceptual voice parameters.
Collapse
Affiliation(s)
- A Serra
- ENT Department of University of Catania, Italy
| | - G Spinato
- ENT Department, Rovigo Provincial Hospital, Italy
| | - R Spinato
- Provincial ENT Department of Venice, Mestre, Italy
| | - A Conti
- ENT Department of University of Catania, Italy
| | | | - M Di Luca
- ENT Department of University of Catania, Italy
| | - G Campione
- ENT Department of University of Catania, Italy
| | - G Tonoli
- ENT Department, Rovigo Provincial Hospital, Italy
| | - D Politi
- Provincial ENT Department of Venice, Mestre, Italy
| | - V Castro
- ENT Department of University of Catania, Italy
| | - A Maniaci
- ENT Department of University of Catania, Italy
| | - L Maiolino
- ENT Department of University of Catania, Italy
| | - S Cocuzza
- ENT Department of University of Catania, Italy
| |
Collapse
|
46
|
La Fauci V, Costa G, Facciolà A, Conti A, Riso R, Squeri R. Humidifiers for oxygen therapy: what risk for reusable and disposable devices? J Prev Med Hyg 2017; 58:E161-E165. [PMID: 28900356 PMCID: PMC5584085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Nosocomial pneumonia accounts for the vast majority of healthcare-associated infections (HAI). Although numerous medical devices have been discussed as potential vehicles for microorganisms, very little is known about the role played by oxygen humidifiers as potential sources of nosocomial pathogens. The purpose of this research was to evaluate the safety of the reuse of humidifiers by analysing the rate of microbial contamination in reusable and disposable oxygen humidifiers used during therapy, and then discuss their potential role in the transmission of respiratory pathogens. METHODS Water samples from reusable and disposable oxygen humidifiers were collected from different wards of the University Hospital of Messina, Italy, where nosocomial pneumonia has a higher incidence rate due to the "critical" clinical conditions of inpatients. In particular, we monitored the Internal Medicine and Pulmonology wards for the medical area; the General Surgery and Thoracic and Cardiovascular Surgery wards for the surgical area and the Intensive Care Unit and Neonatal Intensive Care Unit for the emergency area. The samples were always collected after a period of 5 days from initial use for both types of humidifiers. Samples were processed using standard bacteriological techniques and microbial colonies were identified using manual and automated methods. RESULTS High rates of microbial contamination were observed in samples from reusable oxygen humidifiers employed in medical (83%), surgical (77%) and emergency (50%) areas. The most relevant pathogens were Pseudomonas aeruginosa, amongst the Gram-negative bacteria, and Staphylococcus aureus, amongst the Gram-positive bacteria. Other pathogens were detected in lower percentage. The disposable oxygen humidifier samples showed no contamination. CONCLUSIONS This research presents evidence of the high rate and type of microbial contamination of reusable humidifiers employed for oxygen therapy. These devices may thus be involved in the transmission of potential pathogens. It could be important, for the prevention of nosocomial pneumonia, to replace them with singleuse humidifiers for which the absence of microbial contamination has been confirmed.
Collapse
Affiliation(s)
- V. La Fauci
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy;,Correspondence: Vincenza La Fauci, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, A.O.U. Policlinico "G. Martino", Torre Biologica 1° Piano, via Consolare Valeria, 98125 MESSINA, Italy - Te.: +39 090 2213620 - Fax +39 090 2213351 - E-mail:
| | - G.B. Costa
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy
| | - A. Facciolà
- Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Italy
| | - A. Conti
- Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Italy
| | - R. Riso
- Postgraduate Medical School in Hygiene and Preventive Medicine, University of Messina, Italy
| | - R. Squeri
- Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Italy
| |
Collapse
|
47
|
Odorici G, Mandel VD, Giannetti A, Pellacani G, Conti A. Clinical features and in vivo reflectance confocal microscopy of an atypical presentation of Herpesvirus-2 and Cytomegalovirus co-infection of the intergluteal sulcus. Skin Res Technol 2017; 23:619-620. [DOI: 10.1111/srt.12366] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/10/2017] [Indexed: 11/29/2022]
Affiliation(s)
- G. Odorici
- Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine; Dermatology Unit; University of Modena and Reggio Emilia; Modena Italy
| | - V. D. Mandel
- Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine; Dermatology Unit; University of Modena and Reggio Emilia; Modena Italy
| | - A. Giannetti
- Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine; Dermatology Unit; University of Modena and Reggio Emilia; Modena Italy
| | - G. Pellacani
- Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine; Dermatology Unit; University of Modena and Reggio Emilia; Modena Italy
| | - A. Conti
- Department of Surgical, Medical, Dental and Morphological Sciences with Interest transplant, Oncological and Regenerative Medicine; Dermatology Unit; University of Modena and Reggio Emilia; Modena Italy
| |
Collapse
|
48
|
Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, Costanzo A, Conti A, Dapavo P, De Simone C, Foti C, Naldi L, Offidani A, Parodi A, Piaserico S, Prignano F, Rongioletti F, Stingeni L, Talamonti M, Girolomoni G. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol 2017; 31:774-790. [PMID: 28244153 DOI: 10.1111/jdv.14114] [Citation(s) in RCA: 117] [Impact Index Per Article: 16.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2016] [Accepted: 12/21/2016] [Indexed: 02/06/2023]
Abstract
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, appropriate use of therapeutic resources is very important. Management of psoriasis in daily clinical practice is highly variable because many issues are still debated and not definitely addressed by the evidence-based medicine. Moreover, the different availability and reimbursability of drugs in each country justifies national guidelines. Expert consensus can provide helpful guidelines for optimizing patient care. A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to participate in the guidelines expert panel who aimed to reach consensus on the factors influencing psoriasis severity, the indications for systemic treatments, the parameters to be considered in the choice of treatment, and the factors to be considered in the choice of biological treatment. The recommendations for the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatology and Venereology psoriasis guidelines. Recommendations on the treatment of psoriasis in special patient populations were also agreed. The final document was discussed in a meeting moderated by a facilitator with participation of the entire group and adopting a nominal group technique to reach consensus. A statement was regarded as consented when agreement was achieved by at least 75% of the voting experts according to the Delphi procedure.
Collapse
Affiliation(s)
- P Gisondi
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| | - G Altomare
- Department of Dermatology and Venereology, I.R.C.C.S. Istituto Ortopedico Galeazzi, University of Milan, Milano, Italy
| | - F Ayala
- Department of Dermatology, University of Naples Federico II, Napoli, Italy
| | - F Bardazzi
- Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
| | - L Bianchi
- Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
| | - A Chiricozzi
- Department of Dermatology, University of Pisa, Pisa, Italy
| | - A Costanzo
- Department of Dermatology, Humanitas Research Hospital, Rozzano, Italy
| | - A Conti
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - P Dapavo
- Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy
| | - C De Simone
- Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy
| | - C Foti
- Department of Biomedical Science and Human Oncology, Section of Dermatology, University of Bari, Bari, Italy
| | - L Naldi
- Department of Dermatology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
| | - A Offidani
- Department of Clinical and Molecular Sciences, Dermatology Unit, Polytechnic Marche University, Ancona, Italy
| | - A Parodi
- Department of Dermatology, University of Genoa, Genova, Italy
| | - S Piaserico
- Department of Dermatology, University of Padua, Padova, Italy
| | - F Prignano
- Department of Dermatology, University of Florence, Firenze, Italy
| | - F Rongioletti
- Department of Medical Sciences and Public Health, Section of Dermatology, University of Cagliari, Cagliari, Italy
| | - L Stingeni
- Department of Medicine, Section of Clinical, Allergological and Venereological Dermatology, University of Perugia, Perugia, Italy
| | - M Talamonti
- Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
| | - G Girolomoni
- Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy
| |
Collapse
|
49
|
Esposito M, Gisondi P, Conti A, Giunta A, del Giglio M, Di Mercurio M, Veneziano L, Ferrucci G, Bianchi L, Chimenti S, Girolomoni G. Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study. J Eur Acad Dermatol Venereol 2017; 31:863-869. [DOI: 10.1111/jdv.14145] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2016] [Accepted: 12/12/2016] [Indexed: 12/01/2022]
Affiliation(s)
- M. Esposito
- Department of Dermatology; University of Rome ‘Tor Vergata’; Rome Italy
| | - P. Gisondi
- Department of Dermatology; University of Verona; Verona Italy
| | - A. Conti
- Department of Dermatology; University of Modena and Reggio Emilia; Modena Italy
| | - A. Giunta
- Department of Dermatology; University of Rome ‘Tor Vergata’; Rome Italy
| | - M. del Giglio
- Department of Dermatology; University of Verona; Verona Italy
| | - M. Di Mercurio
- Department of Dermatology; University of Verona; Verona Italy
| | - L. Veneziano
- Department of Dermatology; University of Modena and Reggio Emilia; Modena Italy
| | | | - L. Bianchi
- Department of Dermatology; University of Rome ‘Tor Vergata’; Rome Italy
| | - S. Chimenti
- Department of Dermatology; University of Rome ‘Tor Vergata’; Rome Italy
| | - G. Girolomoni
- Department of Dermatology; University of Verona; Verona Italy
| |
Collapse
|
50
|
Piaserico S, Dapavo P, Conti A, Gisondi P, Russo FP. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. J Eur Acad Dermatol Venereol 2017; 31:1853-1859. [PMID: 28146345 DOI: 10.1111/jdv.14146] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2016] [Accepted: 01/16/2017] [Indexed: 02/06/2023]
Abstract
BACKGROUND Little data are available about the safety of TNF-α inhibitors in patients with HCV and HBV infection. In particular, data concerning the use of adalimumab in patients with psoriasis and concomitant viral hepatitis are lacking and little is known about the drug's real safety in this context. OBJECTIVE To assess the long-term safety of adalimumab in a group of 17 consecutive psoriatic patients affected by chronic HBV infection and 20 consecutive psoriatic patients affected by chronic HCV infection. METHODS Thirty-seven consecutive patients with psoriasis and concomitant HBV or HCV infection being treated with adalimumab at four Italian referral centres (Modena, Padova, Verona and Turin) were assessed before the treatment and at the end of follow-up. Viral load and radiological studies (echography, Fibroscan) were also carried out in some of the patients. RESULTS The patients responded well to treatment and did not show any HBV or HCV reactivation in a mean follow-up period of 27 and 40 months, respectively. The fibrosis score in eight HCV patients showed a slight reduction: pretreatment mean value 5.83 and post-treatment mean value 5.65. CONCLUSION The use of adalimumab seems to be safe in patients with severe psoriasis and HBV or HCV infection. Nevertheless, large-scale prospective studies will be able to provide vital information on the impact of anti-TNF treatment on hepatic function in patients with psoriasis and concomitant chronic HCV or HBV infection and appropriate monitoring scheduling.
Collapse
Affiliation(s)
- S Piaserico
- Dermatology Unit, Department of Medicine, University of Padua, Padua, Italy
| | - P Dapavo
- Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy
| | - A Conti
- Dermatology Unit, Department of Medicine and Medical Specialties, University of Modena, Modena, Italy
| | - P Gisondi
- Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy
| | - F P Russo
- Gastroenterology Unit, Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy
| |
Collapse
|